Universitätsklinik für Urologie

Home > Publikationen > Publikationen & Wissenschaft

Publikationen & Wissenschaft

Alle Einträge

05. April 2021 - Asian J Androl
Vomstein K, Reiser E, Pinggera GM, Toerzsoek P, Deininger S, Kriesche T, Biasio W, Lusuardi L, Toth B
Sperm banking before gonadotoxic treatment: is it worth the effort?
Zeige auf PubMed
02. April 2021 - Oncogene
Puhr M, Eigentler A, Handle F, Hackl H, Ploner C, Heidegger I, Schaefer G, Brandt MP, Hoefer J, Van der Pluijm G, Klocker H
Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer.
Zeige auf PubMed
Zum pdf
22. März 2021 - Ther Adv Urol
D'Elia C, Folchini DM, Mian C, Hanspeter E, Schwienbacher C, Spedicato GA, Pycha S, Vjaters E, Degener S, Kafka M, Pycha A, Trenti E
Diagnostic value of Xpert(®) Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer: an update.
Zeige auf PubMed
Zum pdf
13. März 2021 - J Nucl Med
Uprimny C, Bayerschmidt S, Kroiss AS, Fritz J, Nilica B, Svirydenka H, Decristoforo C, von Guggenberg E, Horninger W, Virgolini IJ
Early Injection of Furosemide Increases Detection Rate of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for (68)Ga-PSMA-11 PET/CT.
Zeige auf PubMed
Zum pdf
11. März 2021 - J Pediatr Urol
Silay MS, 't Hoen L, Bhatt N, Quaedackers J, Bogaert G, Dogan HS, Nijman RJM, Rawashdeh Y, Stein R, Tekgul S, Radmayr C
Are there any benefits of using an inlay graft in the treatment of primary hypospadias in children? A systematic review and metanalysis.
Zeige auf PubMed
Zum pdf
11. März 2021 - Am J Pathol
Furlan T, Kirchmair A, Sampson N, Puhr M, Gruber M, Trajanoski Z, Santer FR, Parson W, Handle F, Culig Z
MYC-Mediated Ribosomal Gene Expression Sensitizes Enzalutamide-resistant Prostate Cancer Cells to EP300/CREBBP Inhibitors.
Zeige auf PubMed
Zum pdf
06. März 2021 - J Clin Med
Pichler R, Lindner AK, Schäfer G, Tulchiner G, Staudacher N, Mayr M, Comperat E, Orme JJ, Schachtner G, Thurnher M
Expression of ADAM Proteases in Bladder Cancer Patients with BCG Failure: A Pilot Study.
Zeige auf PubMed
Zum pdf
01. März 2021 - Cancer Immunol Immunother
Tulchiner G, Pichler R, Ulmer H, Staudacher N, Lindner AK, Brunner A, Zelger B, Steinkohl F, Aigner F, Horninger W, Thurnher M
Sex-specific hormone changes during immunotherapy and its influence on survival in metastatic renal cell carcinoma.
Zeige auf PubMed
Zum pdf
16. Februar 2021 - J Pediatr Urol
't Hoen LA, Bogaert G, Radmayr C, Dogan HS, Nijman RJM, Quaedackers J, Rawashdeh YF, Silay MS, Tekgul S, Bhatt NR, Stein R
Update of the EAU/ESPU guidelines on urinary tract infections in children.
Zeige auf PubMed
Zum pdf
15. Februar 2021 - Hypertension
Vlahou A, Hallinan D, Apweiler R, Argiles A, Beige J, Benigni A, Bischoff R, Black PC, Boehm F, Céraline J, Chrousos GP, Delles C, Evenepoel P, Fridolin I, Glorieux G, van Gool AJ, Heidegger I, Ioannidis JPA, Jankowski J, Jankowski V, Jeronimo C, Kamat AM, Masereeuw R, Mayer G, Mischak H, Ortiz A, Remuzzi G, Rossing P, Schanstra JP, Schmitz-Dräger BJ, Spasovski G, Staessen JA, Stamatialis D, Stenvinkel P, Wanner C, Williams SB, Zannad F, Zoccali C, Vanholder R
Data Sharing Under the General Data Protection Regulation: Time to Harmonize Law and Research Ethics?
Zeige auf PubMed
Zum pdf
11. Februar 2021 - Transl Lung Cancer Res
Kocher F, Amann A, Zimmer K, Geisler S, Fuchs D, Pichler R, Wolf D, Kurz K, Seeber A, Pircher A
High indoleamine-2,3-dioxygenase 1 (IDO) activity is linked to primary resistance to immunotherapy in non-small cell lung cancer (NSCLC).
Zeige auf PubMed
Zum pdf
10. Februar 2021 - N Engl J Med
Pircher A, Heidegger I, Wolf D
Atezolizumab for PD-L1-Selected Patients with NSCLC.
Zeige auf PubMed
Zum pdf
31. Jänner 2021 - Urol Int
Mumm JN, Klehr B, Rodler S, Kretschmer A, Vilsmaier T, Westhofen T, Chaloupka M, Schulz GB, Gozzi C, Rehder P, May F, Homberg R, Stief CG, Grabbert M, Bauer RM
Five-Year Results of a Prospective Multicenter Trial: AdVance XP for Postprostatectomy-Incontinence in Patients with Favorable Prognostic Factors.
Zeige auf PubMed
Zum pdf
19. Jänner 2021 - Br J Pharmacol
Gruenbacher G, Gander H, Dobler G, Rahm A, Klaver D, Thurnher M
The human G protein-coupled ATP receptor P2Y(11) is a target for anti-inflammatory strategies.
Zeige auf PubMed
Zum pdf
17. Jänner 2021 - BJU Int
Tulchiner G, Brunner A, Schmidinger M, Staudacher N, Orme JJ, Thurnher M, Horninger W, Culig Z, Pichler R
CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma.
Zeige auf PubMed
Zum pdf
12. Jänner 2021 - Int J Mol Sci
Lindner AK, Schachtner G, Tulchiner G, Thurnher M, Untergasser G, Obrist P, Pipp I, Steinkohl F, Horninger W, Culig Z, Pichler R
Lynch Syndrome: Its Impact on Urothelial Carcinoma.
Zeige auf PubMed
Zum pdf
10. Jänner 2021 - Eur Urol Oncol
Steuber T, Heidegger I, Kafka M, Roeder MA, Chun F, Preisser F, Palisaar RJ, Hanske J, Budaeus L, Schiess R, Keller T, Semjonow A, Hammerer P, Manka L, Ecke T, Schwentner C, Ohlmann C
PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate Cancer.
Zeige auf PubMed
Zum pdf
09. Jänner 2021 - Anticancer Res
KÖditz B, Stog A, GÖbel H, Heidegger I, Fries J, Heidenreich A, VON Brandenstein M
Vimentin 3 Expression in Prostate Cancer Cells.
Zeige auf PubMed
Zum pdf
07. Jänner 2021 - Urol Int
Kliesch S, Schmidt S, Wilborn D, Aigner C, Albrecht W, Bedke J, Beintker M, Beyersdorff D, Bokemeyer C, Busch J, Classen J, de Wit M, Dieckmann KP, Diemer T, Dieing A, Gockel M, Göckel-Beining B, Hakenberg OW, Heidenreich A, Heinzelbecker J, Herkommer K, Hermanns T, Kaufmann S, Kornmann M, Kotzerke J, Krege S, Kristiansen G, Lorch A, Müller AC, Oechsle K, Ohloff T, Oing C, Otto U, Pfister D, Pichler R, Recken H, Rick O, Rudolph Y, Ruf C, Schirren J, Schmelz H, Schmidberger H, Schrader M, Schweyer S, Seeling S, Souchon R, Winter C, Wittekind C, Zengerling F, Zermann DH, Zillmann R, Albers P
Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages.
Zeige auf PubMed
Zum pdf
29. Dezember 2020 - Hum Reprod
Rudnik-Schöneborn S, Messner M, Vockel M, Wirleitner B, Pinggera GM, Witsch-Baumgartner M, Murtinger M, Kliesch S, Swoboda M, Sänger N, Zschocke J, Tüttelmann F
Andrological findings in infertile men with two (biallelic) CFTR mutations: results of a multicentre study in Germany and Austria comprising 71 patients.
Zeige auf PubMed
04. Dezember 2020 - Macromol Biosci
Wurm F, Pinggera GM, Pham T, Bechtold T
Investigation on the Behavior of κ -Carrageenan Hydrogels for Compressive Intra-Vessel Disintegration.
Zeige auf PubMed
Zum pdf
27. November 2020 - Eur Urol Oncol
Heidegger I, Necchi A, Pircher A, Tsaur I, Marra G, Kasivisvanathan V, Kretschmer A, Mathieu R, Ceci F, van den Bergh RCN, Thibault C, Tilki D, Valerio M, Surcel C, Gandaglia G, EAU-YAU Prostate Cancer Working Party
A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy?
Zeige auf PubMed
Zum pdf
11. November 2020 - Cancers (Basel)
Heidegger I
Recent Scientific Developments in Metastatic Prostate Cancer.
Zeige auf PubMed
Zum pdf
05. November 2020 - Cancers (Basel)
Muresan XM, Bouchal J, Culig Z, Souček K
Toll-Like Receptor 3 in Solid Cancer and Therapy Resistance.
Zeige auf PubMed
Zum pdf
02. November 2020 - World J Urol
Surcel C, Mirvald C, Tsaur I, Borgmann H, Heidegger I, Labanaris AP, Sinescu I, Tilki D, Ploussard G, Briganti A, Montorsi F, Mathieu R, Valerio M, Jinga V, Badescu D, Radavoi D, van den Bergh RCN, Gandaglia G, Kretschmer A, as part of the EAU-YAU PCa Working Party
Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer.
Zeige auf PubMed
Zum pdf
20. Oktober 2020 - Cancers (Basel)
Bertok T, Jane E, Bertokova A, Lorencova L, Zvara P, Smolkova B, Kucera R, Klocker H, Tkac J
Validating fPSA Glycoprofile as a Prostate Cancer Biomarker to Avoid Unnecessary Biopsies and Re-Biopsies.
Zeige auf PubMed
Zum pdf
13. Oktober 2020 - Urologe A
Kunz Y, Horninger W, Pinggera GM
[What should urologists know about SARS-CoV-2? Risk analysis for urological operations and recommendations for action in clinical routine].
Zeige auf PubMed
Zum pdf
09. Oktober 2020 - Int J Cancer
Aksoy O, Pencik J, Hartenbach M, Moazzami AA, Schlederer M, Balber T, Varady A, Philippe C, Baltzer PA, Mazumder B, Whitchurch JB, Roberts CJ, Haitel A, Herac M, Susani M, Mitterhauser M, Marculescu R, Stangl-Kremser J, Hassler MR, Kramer G, Shariat SF, Turner SD, Tichy B, Oppelt J, Pospisilova S, Hartenbach S, Tangermann S, Egger G, Neubauer HA, Moriggl R, Culig Z, Greiner G, Hoermann G, Hacker M, Heery DM, Merkel O, Kenner L
Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer.
Zeige auf PubMed
Zum pdf
30. September 2020 - Cancers (Basel)
Pichler R
Immune Checkpoint Inhibitors in Uro-Oncology: Urgent Call for Biomarkers.
Zeige auf PubMed
Zum pdf
23. September 2020 - Eur Urol Focus
Kretschmer A, Mazzone E, Barletta F, Leni R, Heidegger I, Tsaur I, van den Bergh RCN, Valerio M, Marra G, Kasivisvanathan V, Buchner A, Stief CG, Briganti A, Montorsi F, Tilki D, Gandaglia G, EAU-YAU Prostate Cancer Working Party
Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate.
Zeige auf PubMed
Zum pdf
16. September 2020 - Eur Urol Oncol
Marra G, Valerio M, Heidegger I, Tsaur I, Mathieu R, Ceci F, Ploussard G, van den Bergh RCN, Kretschmer A, Thibault C, Ost P, Tilki D, Kasivisvanathan V, Moschini M, Sanchez-Salas R, Gontero P, Karnes RJ, Montorsi F, Gandaglia G, EAU-YAU Prostate Cancer Working Party
Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review.
Zeige auf PubMed
Zum pdf
12. September 2020 - J Clin Med
Staudacher N, Tulchiner G, Bates K, Ladurner M, Kafka M, Aigner F, Pichler R, Horninger W
Organ-Sparing Surgery in Testicular Tumor: Is This the Right Approach for Lesions ≤ 20 mm?
Zeige auf PubMed
Zum pdf
27. August 2020 - N Engl J Med
Heidegger I, Pircher A
Olaparib for Metastatic Castration-Resistant Prostate Cancer.
Zeige auf PubMed
Zum pdf
14. August 2020 - PLoS One
Erb HHH, Bodenbender J, Handle F, Diehl T, Donix L, Tsaur I, Gleave M, Haferkamp A, Huber J, Fuessel S, Juengel E, Culig Z, Thomas C
Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer.
Zeige auf PubMed
Zum pdf
01. August 2020 - Cancers (Basel)
Kafka M, Mayr F, Temml V, Möller G, Adamski J, Höfer J, Schwaiger S, Heidegger I, Matuszczak B, Schuster D, Klocker H, Bektic J, Stuppner H, Eder IE
Dual Inhibitory Action of a Novel AKR1C3 Inhibitor on Both Full-Length AR and the Variant AR-V7 in Enzalutamide Resistant Metastatic Castration Resistant Prostate Cancer.
Zeige auf PubMed
Zum pdf
26. Juli 2020 - Cancers (Basel)
Fendt L, Fazzini F, Weissensteiner H, Bruckmoser E, Schönherr S, Schäfer G, Losso JL, Streiter GA, Lamina C, Rasse M, Klocker H, Kofler B, Kloss-Brandstätter A, Huck CW, Kronenberg F, Laimer J
Profiling of Mitochondrial DNA Heteroplasmy in a Prospective Oral Squamous Cell Carcinoma Study.
Zeige auf PubMed
Zum pdf
13. Juli 2020 - Eur Urol Focus
Tsaur I, Heidegger I, van den Bergh RCN, Bektic J, Borgmann H, Foti S, Hunting JCB, Kretschmer A, Ploussard G, Tilki D, Gandaglia G, Dotzauer R, EAU-YAU Prostate Cancer Working Party
Treatment of Metastasized Prostate Cancer Beyond Progression After Upfront Docetaxel-A Real-world Data Assessment.
Zeige auf PubMed
Zum pdf
29. Juni 2020 - Liver Transpl
Paine CH, Pichler RH
Intraoperative Renal Replacement Therapy for Liver Transplantation: Is There Really a Benefit?
Zeige auf PubMed
Zum pdf
28. Juni 2020 - Urol Oncol
Kafka M, Eder IE, Klocker H, Heidegger I
Emerging promising biomarkers for treatment decision in metastatic castration-resistant prostate cancer.
Zeige auf PubMed
Zum pdf
25. Juni 2020 - Mol Oncol
Drápela S, Khirsariya P, van Weerden WM, Fedr R, Suchánková T, Búzová D, Červený J, Hampl A, Puhr M, Watson WR, Culig Z, Krejčí L, Paruch K, Souček K
The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe.
Zeige auf PubMed
Zum pdf
21. Juni 2020 - BJU Int
Kunz Y, Horninger W, Pinggera GM
Are urologists in trouble with SARS-CoV-2? Reflections and recommendations for specific interventions.
Zeige auf PubMed
Zum pdf
21. Juni 2020 - Urologe A
Köhn FM, Kliesch S, Pinggera GM, Schuppe HC, Tüttelmann F
[Andrological diagnostics prior to treatment by assisted reproduction].
Zeige auf PubMed
Zum pdf
04. Juni 2020 - Urol Case Rep
Rehder P, Pedrini M, Jelisejevas LA, Gulacsi A, Horninger W, Stuehmeier J
Urethro-cavernosal-spongiosal fistula after intralesional mitomycin C for recurrent urethral stricture disease.
Zeige auf PubMed
Zum pdf
04. Juni 2020 - Urol Case Rep
Rehder P, Barkhuizen M, Redecker A, Oeconomou A, Madersbacher H, Stuehmeier J
Salvage perineal-retropubic AUS cuff in paraplegic patient with exstrophy-epispadias complex after previous cuff erosion at bladder neck.
Zeige auf PubMed
Zum pdf
04. Juni 2020 - Urol Case Rep
Kivi M, Ahlberg A, Okas R, Stuehmeier J, Pedrini M, Rehder P
Female urethral avulsion and bladder neck closure: What now? Trigonal tubularization with placement of an artificial urinary sphincter.
Zeige auf PubMed
Zum pdf
31. Mai 2020 - Eur J Pediatr
Tekgul S, Stein R, Bogaert G, Undre S, Nijman RJM, Quaedackers J, 't Hoen L, Kocvara R, Silay MS, Radmayr C, Dogan HS
EAU-ESPU guidelines recommendations for daytime lower urinary tract conditions in children.
Zeige auf PubMed
Zum pdf
20. Mai 2020 - Urol Case Rep
Pedrini M, Stuehmeier J, Jelisejevas LA, Gulacsi A, Horninger W, Rehder P
Excessive fibrosis and non-function after ATOMS (adjustable transobturator male system): A case of capsular contracture?
Zeige auf PubMed
Zum pdf
20. Mai 2020 - Urol Case Rep
Rehder P, Stuehmeier J, Jelisejevas LA, Gulacsi A, Horninger W, Pedrini M
World record: Single AMS 800 artificial urinary sphincter functioning uninterrupted for 29 years in male paraplegic patient.
Zeige auf PubMed
Zum pdf
14. Mai 2020 - Cancers (Basel)
Seles M, Hutterer GC, Foßelteder J, Svoboda M, Resel M, Barth DA, Pichler R, Bauernhofer T, Zigeuner RE, Pummer K, Slaby O, Klec C, Pichler M
Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell Cancer.
Zeige auf PubMed
Zum pdf
10. Mai 2020 - Eur J Nucl Med Mol Imaging
Uprimny C, Bayerschmidt S, Kroiss AS, Fritz J, Nilica B, Svirydenka A, Decristoforo C, di Santo G, von Guggenberg E, Horninger W, Virgolini IJ
Impact of forced diuresis with furosemide and hydration on the halo artefact and intensity of tracer accumulation in the urinary bladder and kidneys on [(68)Ga]Ga-PSMA-11-PET/CT in the evaluation of prostate cancer patients.
Zeige auf PubMed
Zum pdf
08. Mai 2020 - Eur Urol
Ribal MJ, Cornford P, Briganti A, Knoll T, Gravas S, Babjuk M, Harding C, Breda A, Bex A, GORRG Group, Rassweiler JJ, Gözen AS, Pini G, Liatsikos E, Giannarini G, Mottrie A, Subramaniam R, Sofikitis N, Rocco BMC, Xie LP, Witjes JA, Mottet N, Ljungberg B, Rouprêt M, Laguna MP, Salonia A, Bonkat G, Blok BFM, Türk C, Radmayr C, Kitrey ND, Engeler DS, Lumen N, Hakenberg OW, Watkin N, Hamid R, Olsburgh J, Darraugh J, Shepherd R, Smith EJ, Chapple CR, Stenzl A, Van Poppel H, Wirth M, Sønksen J, N'Dow J, EAU Section Offices and the EAU Guidelines Panels
European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era.
Zeige auf PubMed
Zum pdf
07. Mai 2020 - Urol Case Rep
Rehder P, Jelisejevas LA, Pedrini M, Gulacsi A, Horninger W, Stuehmeier J
Intrapelvic bulboprostatic repair after urethral distraction injury and failed bulbomembranous anastomosis.
Zeige auf PubMed
Zum pdf
06. Mai 2020 - Anticancer Res
Kafka M, Strohhacker K, Aigner F, Steinkohl F, Horninger W, Pichler R, Heidegger I
Incidental Testicular Pathologies in Patients With Idiopathic Hydrocele Testis: Is Preoperative Scrotal Ultrasound Justified?
Zeige auf PubMed
Zum pdf
16. April 2020 - J Pediatr Urol
Quaedackers JSLT, Stein R, Bhatt N, Dogan HS, Hoen L, Nijman RJM, Radmayr C, Silay MS, Tekgul S, Bogaert G
Clinical and surgical consequences of the COVID-19 pandemic for patients with pediatric urological problems: Statement of the EAU guidelines panel for paediatric urology, March 30 2020.
Zeige auf PubMed
Zum pdf
10. April 2020 - Eur Urol
Gandaglia G, Martini A, Ploussard G, Fossati N, Stabile A, De Visschere P, Borgmann H, Heidegger I, Steinkohl F, Kretschmer A, Marra G, Mathieu R, Surcel C, Tilki D, Tsaur I, Valerio M, Van den Bergh R, Ost P, Gontero P, Montorsi F, Briganti A, EAU-YAU Prostate Cancer Working Group
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection.
Zeige auf PubMed
09. April 2020 - Front Mol Biosci
Drápela S, Bouchal J, Jolly MK, Culig Z, Souček K
ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance.
Zeige auf PubMed
Zum pdf
03. April 2020 - Cells
Nussbaumer O, Thurnher M
Functional Phenotypes of Human Vγ9Vδ2 T Cells in Lymphoid Stress Surveillance.
Zeige auf PubMed
Zum pdf
22. März 2020 - Nat Commun
Schöpf B, Weissensteiner H, Schäfer G, Fazzini F, Charoentong P, Naschberger A, Rupp B, Fendt L, Bukur V, Giese I, Sorn P, Sant'Anna-Silva AC, Iglesias-Gonzalez J, Sahin U, Kronenberg F, Gnaiger E, Klocker H
OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation.
Zeige auf PubMed
Zum pdf
18. März 2020 - Oncotarget
Dorris ER, O'Neill A, Treacy A, Klocker H, Teltsh O, Kay E, Watson RW
The transcription factor CUX1 negatively regulates invasion in castrate resistant prostate cancer.
Zeige auf PubMed
Zum pdf
12. März 2020
- BJUI COMPASS Klocker, H., Golding, B., Weber, S., Steiner, E., Tennstedt, P., Keller, T., Schiess, R., Gillessen, S., Horninger, W., and Steuber, T. Development and validation of a novel multivariate risk score to guide biopsy decision for the diagnosis of clinically significant prostate cancer. https://onlinelibrary.wiley.com/doi/abs/10.1002/bco2.8
18. März 2020 - Oncotarget
Dorris ER, O'Neill A, Treacy A, Klocker H, Teltsh O, Kay E, Watson RW
The transcription factor CUX1 negatively regulates invasion in castrate resistant prostate cancer.
Zeige auf PubMed
Zum pdf
18. März 2020 - Oncotarget
Dorris ER, O'Neill A, Treacy A, Klocker H, Teltsh O, Kay E, Watson RW
The transcription factor CUX1 negatively regulates invasion in castrate resistant prostate cancer.
Zeige auf PubMed
Zum pdf
25. Februar 2020 - Eur Urol Focus
Kretschmer A, Ploussard G, Heidegger I, Tsaur I, Borgmann H, Surcel C, Mathieu R, de Visschere P, Valerio M, van den Bergh RCN, Marra G, Thibault C, Ost P, Gandaglia G, Tilki D, EAU-YAU Prostate Cancer Working Party
Health-related Quality of Life in Patients with Advanced Prostate Cancer: A Systematic Review.
Zeige auf PubMed
Zum pdf
16. Februar 2020 - Cancers (Basel)
Eigentler A, Tymoszuk P, Zwick J, Schmitz AA, Pircher A, Kocher F, Schlicker A, Lesche R, Schäfer G, Theurl I, Klocker H, Heidegger I
The Impact of Cand1 in Prostate Cancer.
Zeige auf PubMed
Zum pdf
05. Februar 2020 - Ann Transl Med
Pichler R, Schmidinger M
Can immune biomarkers predict benefit from targeted agents in metastatic renal cell carcinoma?
Zeige auf PubMed
Zum pdf
26. Jänner 2020 - Cell Commun Signal
Neuwirt H, Bouchal J, Kharaishvili G, Ploner C, Jöhrer K, Pitterl F, Weber A, Klocker H, Eder IE
Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis.
Zeige auf PubMed
Zum pdf
25. Jänner 2020 - Cancer Cytopathol
Trenti E, Pycha S, Mian C, Schwienbacher C, Hanspeter E, Kafka M, Spedicato GA, Vjaters E, Degener S, Pycha A, D'Elia C
Comparison of 2 new real-time polymerase chain reaction-based urinary markers in the follow-up of patients with non-muscle-invasive bladder cancer.
Zeige auf PubMed
Zum pdf
19. Jänner 2020 - Urol Oncol
Heidegger I, Brandt MP, Heck MM
Treatment of non-metastatic castration resistant prostate cancer in 2020: What is the best?
Zeige auf PubMed
18. Jänner 2020 - Endocr Relat Cancer
Gruber M, Ferrone L, Puhr M, Santer FR, Furlan T, Eder IE, Sampson N, Schäfer G, Handle F, Culig Z
p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer.
Zeige auf PubMed
Zum pdf
27. Dezember 2019 - Geburtshilfe Frauenheilkd
Toth B, Baston-Büst DM, Behre HM, Bielfeld A, Bohlmann M, Bühling K, Dittrich R, Goeckenjan M, Hancke K, Kliesch S, Köhn FM, Krüssel J, Kuon R, Liebenthron J, Nawroth F, Nordhoff V, Pinggera GM, Rogenhofer N, Rudnik-Schöneborn S, Schuppe HC, Schüring A, Seifert-Klauss V, Strowitzki T, Tüttelmann F, Vomstein K, Wildt L, Wischmann T, Wunder D, Zschocke J
Diagnosis and Treatment Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 2, Hemostaseology, Andrology, Genetics and History of Malignant Disease.
Zeige auf PubMed
Zum pdf
27. Dezember 2019 - Geburtshilfe Frauenheilkd
Toth B, Baston-Büst DM, Behre HM, Bielfeld A, Bohlmann M, Bühling K, Dittrich R, Goeckenjan M, Hancke K, Kliesch S, Köhn FM, Krüssel J, Kuon R, Liebenthron J, Nawroth F, Nordhoff V, Pinggera GM, Rogenhofer N, Rudnik-Schöneborn S, Schuppe HC, Schüring A, Seifert-Klauss V, Strowitzki T, Tüttelmann F, Vomstein K, Wildt L, Wischmann T, Wunder D, Zschocke J
Diagnosis and Therapy Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 1, Basic Assessment of the Woman.
Zeige auf PubMed
Zum pdf
18. Dezember 2019 - Am J Pathol
Pichler R, Lindner AK, Compérat E, Obrist P, Schäfer G, Todenhöfer T, Horninger W, Culig Z, Untergasser G
Amplification of 7p12 Is Associated with Pathologic Nonresponse to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
Zeige auf PubMed
Zum pdf
14. Dezember 2019 - Prostate
Gruber M, Handle F, Culig Z
The stem cell inhibitor salinomycin decreases colony formation potential and tumor-initiating population in docetaxel-sensitive and docetaxel-resistant prostate cancer cells.
Zeige auf PubMed
Zum pdf
13. Dezember 2019 - Eur Urol
Radmayr C
Re: Cancer Screening in the Pediatric Cancer Patient: A Focus on Genitourinary Malignancies, and Why Does a Urologist Need to Know About This?
Zeige auf PubMed
Zum pdf
04. Dezember 2019 - Neurourol Urodyn
Stein R, Bogaert G, Dogan HS, Hoen L, Kocvara R, Nijman RJM, Quaedackers J, Rawashdeh YF, Silay MS, Tekgul S, Radmayr C
EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part II operative management.
Zeige auf PubMed
Zum pdf
04. Dezember 2019 - Neurourol Urodyn
Bogaert G, Stein R, Undre S, Nijman RJM, Quadackers J, 't Hoen L, Kocvara R, Silay S, Tekgul S, Radmayr C, Dogan HS
Practical recommendations of the EAU-ESPU guidelines committee for monosymptomatic enuresis-Bedwetting.
Zeige auf PubMed
Zum pdf
29. November 2019 - Eur J Nucl Med Mol Imaging
Maffey-Steffan J, Scarpa L, Svirydenka A, Nilica B, Mair C, Buxbaum S, Bektic J, von Guggenberg E, Uprimny C, Horninger W, Virgolini I
The (68)Ga/(177)Lu-theragnostic concept in PSMA-targeting of metastatic castration-resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up.
Zeige auf PubMed
Zum pdf
30. November 2019 - Cancer Treat Rev
Heidegger I, Tsaur I, Borgmann H, Surcel C, Kretschmer A, Mathieu R, Visschere P, Valerio M, van den Bergh RCN, Ost P, Tilki D, Gandaglia G, Ploussard G, EAU-YAU Prostate Cancer Working Party
Hereditary prostate cancer - Primetime for genetic testing?
Zeige auf PubMed
Zum pdf
15. November 2019 - Neurourol Urodyn
Stein R, Bogaert G, Dogan HS, Hoen L, Kocvara R, Nijman RJM, Quadackers JSLT, Rawashdeh YF, Silay MS, Tekgul S, Radmayr C
EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part I diagnostics and conservative treatment.
Zeige auf PubMed
Zum pdf
04. November 2019 - Clin Genitourin Cancer
Hebenstreit D, Pichler R, Heidegger I
Drug-Drug Interactions in Prostate Cancer Treatment.
Zeige auf PubMed
Zum pdf
19. Oktober 2019 - BMC Urol
Rehder P, Rehwald R, Böhm JM, Grams AE, Loizides A, Pedrini M, Stühmeier J, Glodny B
Supernumerary kidneys: a clinical and radiological analysis of nine cases.
Zeige auf PubMed
Zum pdf
16. Oktober 2019 - Urol Int
D'Elia C, Mian C, Hanspeter E, Ladurner C, Palermo SM, Pycha S, Saleh O, Cai T, Spoladore G, Kafka M, Pycha A, Trenti E
Efficacy and Safety of Two Fosfomycin Regimens as Antimicrobial Prophylaxis for Transrectal Prostate Biopsy: A Randomised Study.
Zeige auf PubMed
Zum pdf
29. August 2019
- BUCH - Breitenseher Publisher (Verlag) Aigner, F., Pallwein-Prettner, L., and Pinggera, G. Ultraschall des äußeren männlichen Genitals
27. August 2019 - Front Immunol
Gruenbacher G, Gander H, Rahm A, Dobler G, Drasche A, Troppmair J, Nussbaumer W, Thurnher M
The Human G Protein-Coupled ATP Receptor P2Y(11) Is Associated With IL-10 Driven Macrophage Differentiation.
Zeige auf PubMed
Zum pdf
07. August 2019 - J Clin Med
Neuwirt H, Leitner-Lechner I, Kerschbaum J, Ertl M, Pöggsteiner F, Pölt N, Mätzler J, Sprenger-Mähr H, Rudnicki M, Schratzberger P, Eder IE, Mayer G
Efficacy and Safety of Belatacept Treatment in Renal Allograft Recipients at High Cardiovascular Risk-A Single Center Experience.
Zeige auf PubMed
Zum pdf
13. Juli 2019 - Neurourol Urodyn
Grabbert M, Mumm JN, Klehr B, Kretschmer A, Gebhartl P, Gozzi C, Homberg R, May F, Rehder P, Stief CG, Bauer RM
Extended follow-up of the AdVance XP male sling in the treatment of male urinary stress incontinence after 48 months: Results of a prospective and multicenter study.
Zeige auf PubMed
Zum pdf
02. Juli 2019 - Front Oncol
Heidegger I, Pircher A, Pichler R
Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and Therapy.
Zeige auf PubMed
Zum pdf
26. Juni 2019 - Clin Genitourin Cancer
Schmidinger M, Pichler R, Loidl W, Bauernhofer T, Kretz M, Tinchon C, Niedersüß-Beke D, Pfleger G, Wiesinger CG, Vogl U, Mitterberger M, Stöger H, Tulchiner G, Kratochvill F, Gerritsmann H, Mraz B, Marszalek M
Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS Study.
Zeige auf PubMed
Zum pdf
19. Juni 2019 - Urol Case Rep
Stuehmeier J, Pedrini M, Horninger W, Rehder P
Preservation of erectile function by artery sparing dilation of the corpora cavernosa in prolonged priapism.
Zeige auf PubMed
Zum pdf
03. Juni 2019 - Cancer Cytopathol
Trenti E, D'Elia C, Mian C, Schwienbacher C, Hanspeter E, Pycha A, Kafka M, Degener S, Danuser H, Roth S, Pycha A
Diagnostic predictive value of the Bladder EpiCheck test in the follow-up of patients with non-muscle-invasive bladder cancer.
Zeige auf PubMed
Zum pdf
23. Mai 2019 - Curr Radiopharm
Calabria F, Pichler R, Leporace M, Wolfsgruber J, Coscarelli P, Dunzinger A, Schillaci O, Cascini GL, Bagnato A
68Ga/64Cu PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different Tracers.
Zeige auf PubMed
Zum pdf
21. Mai 2019 - Biochim Biophys Acta Mol Cell Res
Culig Z
Epithelial mesenchymal transition and resistance in endocrine-related cancers.
Zeige auf PubMed
Zum pdf
19. Mai 2019 - Neurourol Urodyn
Dogan HS, Stein R, 't Hoen LA, Bogaert G, Nijman RJM, Tekgul S, Quaedackers J, Silay MS, Radmayr C
Are EAU/ESPU pediatric urology guideline recommendations on neurogenic bladder well received by the patients? Results of a survey on awareness in spina bifida patients and caregivers.
Zeige auf PubMed
Zum pdf
17. Mai 2019 - Br J Cancer
Frantzi M, Gomez Gomez E, Blanca Pedregosa A, Valero Rosa J, Latosinska A, Culig Z, Merseburger AS, Luque RM, Requena Tapia MJ, Mischak H, Carrasco Valiente J
CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer.
Zeige auf PubMed
Zum pdf
17. Mai 2019 - Br J Cancer
Frantzi M, Gomez Gomez E, Blanca Pedregosa A, Valero Rosa J, Latosinska A, Culig Z, Merseburger AS, Luque RM, Requena Tapia MJ, Mischak H, Carrasco Valiente J
CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer.
Zeige auf PubMed
Zum pdf
11. Mai 2019 - Eur Urol Focus
Lindner AK, Gruenbacher G, Schachtner G, Thurnher M, Pichler R
Rare, but Severe: Vasculitis and Checkpoint Inhibitors.
Zeige auf PubMed
Zum pdf
08. Mai 2019 - World J Urol
Lindner AK, Schachtner G, Steiner E, Kroiss A, Uprimny C, Steinkohl F, Horninger W, Heidegger I, Madersbacher S, Pichler R
Organ-sparing surgery of penile cancer: higher rate of local recurrence yet no impact on overall survival.
Zeige auf PubMed
Zum pdf
16. April 2019 - Am J Pathol
Culig Z
Centrosomal Proteins in Urothelial Tumors: New Pathways in Disease Pathogenesis.
Zeige auf PubMed
Zum pdf
04. April 2019 - Gerontology
Madersbacher S, Sampson N, Culig Z
Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review.
Zeige auf PubMed
Zum pdf
03. April 2019 - Cancers (Basel)
Pichler R, Compérat E, Klatte T, Pichler M, Loidl W, Lusuardi L, Schmidinger M
Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?
Zeige auf PubMed
Zum pdf
02. April 2019 - Front Pediatr
Tonnhofer U, Hiess M, Metzelder M, Hebenstreit D, Springer A
Midline Incision of a Graft in Staged Hypospadias Repair-Feasible and Durable?
Zeige auf PubMed
Zum pdf
16. März 2019 - J Clin Oncol
Dieckmann KP, Radtke A, Geczi L, Matthies C, Anheuser P, Eckardt U, Sommer J, Zengerling F, Trenti E, Pichler R, Belz H, Zastrow S, Winter A, Melchior S, Hammel J, Kranz J, Bolten M, Krege S, Haben B, Loidl W, Ruf CG, Heinzelbecker J, Heidenreich A, Cremers JF, Oing C, Hermanns T, Fankhauser CD, Gillessen S, Reichegger H, Cathomas R, Pichler M, Hentrich M, Eredics K, Lorch A, Wülfing C, Peine S, Wosniok W, Bokemeyer C, Belge G
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
Zeige auf PubMed
16. März 2019 - Cancer Treat Rev
Tsaur I, Heidegger I, Kretschmer A, Borgmann H, Gandaglia G, Briganti A, de Visschere P, Mathieu R, Valerio M, van den Bergh R, Ost P, Mirvald C, Tilki D, Ploussard G, Surcel C, EAU-YAU Prostate Cancer Working Party
Aggressive variants of prostate cancer - Are we ready to apply specific treatment right now?
Zeige auf PubMed
Zum pdf
01. März 2019 - Tumour Biol
Degasper C, Brunner A, Sampson N, Tsibulak I, Wieser V, Welponer H, Marth C, Fiegl H, Zeimet AG
NADPH oxidase 4 expression in the normal endometrium and in endometrial cancer.
Zeige auf PubMed
Zum pdf
27. Februar 2019 - Eur Urol
Pichler R, Heidegger I
Re: F. Johannes P. van Valenberg, Andrew M. Hiar, Ellen Wallace, et al. Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer. Eur Urol 2019;75:853-60.
Zeige auf PubMed
Zum pdf
09. Jänner 2019 - Eur Urol
Heidegger I, Pichler R
Re: Peter K.-F. Chiu, Chi-Fai Ng, Axel Semjonow, et al. A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings. Eur Urol 2019;75:558-61.
Zeige auf PubMed
Zum pdf
01. Jänner 2019 - Memo
Steinkohl F, Pichler R, Junker D
Short review of biparametric prostate MRI.
Zeige auf PubMed
Zum pdf
01. Jänner 2019 - Memo
Pichler R, Horninger W, Heidegger I
ASCO 2018: highlights of urothelial cancer and prostate cancer.
Zeige auf PubMed
Zum pdf
28. Dezember 2018 - In Vivo
Auer T, Heidegger I, DE Zordo T, Junker D, Jaschke W, Steinkohl F, Aigner F
Fusion Imaging of Contrast-enhanced Ultrasound With CT or MRI for Kidney Lesions.
Zeige auf PubMed
Zum pdf
15. Dezember 2018 - World J Urol
Paffenholz P, Grein K, Heidegger I, Nestler T, Grabbert M, Salem J, Hellmich M, Pfister D, Heidenreich A
Predictors of thrombosis in testicular cancer during platinum-based chemotherapy.
Zeige auf PubMed
Zum pdf
14. Dezember 2018
- EUR SURG Kafka, M., Rehder, P., Maier, H., and Horninger, W. Incidental resetion of a scrotal aggressive angiomyxoma mimiking a permatocele: a case report.
13. Dezember 2018 - Oxid Med Cell Longev
Feichtinger RG, Schäfer G, Seifarth C, Mayr JA, Kofler B, Klocker H
Reduced Levels of ATP Synthase Subunit ATP5F1A Correlate with Earlier-Onset Prostate Cancer.
Zeige auf PubMed
Zum pdf
12. Dezember 2018 - Med Ultrason
Steinkohl F, Luger AK, Pichler R, Bektic J, Rehder P, Lebovici A, Aigner F
Visibility of MRI prostate lesions on B-mode transrectal ultrasound.
Zeige auf PubMed
Zum pdf
13. November 2018 - Eur Urol
Radmayr C
Re: Clinical Outcomes of the Upper Urinary Tract after Ureteral Clipping for Treatment of Low Functioning or Nonfunctioning Renal Moieties.
Zeige auf PubMed
Zum pdf
05. November 2018 - Eur Urol
Ploussard G, Gandaglia G, Borgmann H, de Visschere P, Heidegger I, Kretschmer A, Mathieu R, Surcel C, Tilki D, Tsaur I, Valerio M, van den Bergh R, Ost P, Briganti A, EAU-YAU Prostate Cancer Working Group
Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review.
Zeige auf PubMed
Zum pdf
15. Oktober 2018 - Eur Urol
Silay MS, Hoen L, Quadackaers J, Undre S, Bogaert G, Dogan HS, Kocvara R, Nijman RJM, Radmayr C, Tekgul S, Stein R
Treatment of Varicocele in Children and Adolescents: A Systematic Review and Meta-analysis from the European Association of Urology/European Society for Paediatric Urology Guidelines Panel.
Zeige auf PubMed
Zum pdf
10. Oktober 2018 - Front Oncol
Gruenbacher G, Thurnher M
Mevalonate Metabolism in Cancer Stemness and Trained Immunity.
Zeige auf PubMed
Zum pdf
09. Oktober 2018 - Eur Urol
Culig Z
Identification of Potential Novel Candidates for Understanding Racial Differences in Prostate Cancer.
Zeige auf PubMed
Zum pdf
06. Oktober 2018
- N. Sampson. ARTP Award 2018 of the European Society for Urological Research for Cancer -associated fibroblast heterogeneity within the prostate cancer stromal microinvironment.
Weitere Infos zur Publikation
01. Oktober 2018 - Urol Oncol
Tsaur I, Heidegger I, Kretschmer A, Borgmann H, Mirvald C, Gandaglia G, Briganti A, van den Bergh R, Tilki D, Ost P, Ploussard G, Surcel C, EAU-YAU Prostate Cancer Working Party
Combining anticancer drugs with osteoprotective agents in prostate cancer-A contemporary update.
Zeige auf PubMed
Zum pdf
28. September 2018
- M. Puhr. Science and Innovation Prize 2018 of the German Society of Urology (DGU) for the paper: The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy. Clin Cancer Res, 2018 24:927-938.
Weitere Infos zur Publikation
27. September 2018 - Mol Cancer Ther
Handle F, Puhr M, Schaefer G, Lorito N, Hoefer J, Gruber M, Guggenberger F, Santer FR, Marques RB, van Weerden WM, Claessens F, Erb HHH, Culig Z
The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models.
Zeige auf PubMed
Zum pdf
17. September 2018 - Pathol Oncol Res
Fucic A, Aghajanyan A, Culig Z, Le Novere N
Systems Oncology: Bridging Pancreatic and Castrate Resistant Prostate Cancer.
Zeige auf PubMed
Zum pdf
06. September 2018 - Aktuelle Urol
Heidegger I, Steinkohl F, Horninger W, Pichler R
[Symptomatic urinary obstruction in patients with metastatic malignancies].
Zeige auf PubMed
Zum pdf
23. August 2018 - BJU Int
Culig Z
The way towards understanding possible multiple functions of AR V7 in prostate cancer.
Zeige auf PubMed
Zum pdf
06. August 2018 - World J Urol
Junker D, Steinkohl F, Fritz V, Bektic J, Tokas T, Aigner F, Herrmann TRW, Rieger M, Nagele U
Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations?
Zeige auf PubMed
Zum pdf
04. August 2018 - Prostate
Navone NM, van Weerden WM, Vessella RL, Williams ED, Wang Y, Isaacs JT, Nguyen HM, Culig Z, van der Pluijm G, Rentsch CA, Marques RB, de Ridder CMA, Bubendorf L, Thalmann GN, Brennen WN, Santer FR, Moser PL, Shepherd P, Efstathiou E, Xue H, Lin D, Buijs J, Bosse T, Collins A, Maitland N, Buzza M, Kouspou M, Achtman A, Taylor RA, Risbridger G, Corey E
Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Zeige auf PubMed
Zum pdf
02. August 2018
- A. Pircher, M. Zieher, A. Eigentler, R. Pichler, G. Schafer, J. Fritz, M. Puhr, E. Steiner, W. Horninger, H. Klocker and I. Heidegger....Antidiabetic drugs influence molecular mechanisms in prostate cancer.
26. Juli 2018 - Rev Esp Med Nucl Imagen Mol (Engl Ed)
Kroiss AS, Uprimny C, Pichler R, Gasser RW, Virgolini IJ
A rare case of a (123)I-MIBG SPECT/CT positive, but (68)Ga-DOTA-TOC PET/CT negative pheochromocytoma of the bladder.
Zeige auf PubMed
Zum pdf
25. Juli 2018 - Int J Mol Sci
Weber A, Klocker H, Oberacher H, Gnaiger E, Neuwirt H, Sampson N, Eder IE
Succinate Accumulation Is Associated with a Shift of Mitochondrial Respiratory Control and HIF-1α Upregulation in PTEN Negative Prostate Cancer Cells.
Zeige auf PubMed
Zum pdf
18. Juli 2018 - Cell Death Dis
Slabáková E, Culig Z, Remšík J, Souček K
Correction Alternative mechanisms of miR-34a regulation in cancer.
Zeige auf PubMed
Zum pdf
04. Juli 2018 - World J Urol
Ploussard G, Borgmann H, Briganti A, de Visschere P, Fütterer JJ, Gandaglia G, Heidegger I, Kretschmer A, Mathieu R, Ost P, Sooriakumaran P, Surcel C, Tilki D, Tsaur I, Valerio M, van den Bergh R, EAU-YAU Prostate Cancer Working Group
Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies?
Zeige auf PubMed
Zum pdf
02. Juli 2018 - Clin Genitourin Cancer
Pichler R, Fritz J, Lackner F, Sprung S, Brunner A, Horninger W, Loidl W, Pircher A, Heidegger I
Prognostic Value of Testing PD-L1 Expression After Radical Cystectomy in High-risk Patients.
Zeige auf PubMed
20. Juni 2018 - Eur Urol
Guggenberger F, van de Werken HJG, Erb HHH, Cappellano G, Trattnig K, Handle F, Peer S, Schäfer G, Jenster G, Culig Z, Skvortsova I, Santer FR
Fractionated Radiation of Primary Prostate Basal Cells Results in Downplay of Interferon Stem Cell and Cell Cycle Checkpoint Signatures.
Zeige auf PubMed
Zum pdf
05. Juni 2018 - Aging Male
Kummer KK, Pope HG, Hudson JI, Kemmler G, Pinggera GM, Mangweth-Matzek B
Aging male symptomatology and eating behavior.
Zeige auf PubMed
Zum pdf
27. Mai 2018 - BJU Int
Szarvas T, Sevcenco S, Módos O, Keresztes D, Nyirády P, Csizmarik A, Ristl R, Puhr M, Hoffmann MJ, Niedworok C, Hadaschik B, Maj-Hes A, Shariat SF, Kramer G
Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer.
Zeige auf PubMed
Zum pdf
29. Mai 2018
- I. Heidegger Otto-Kraupp-Preis 2018 für die beste Habilitation, 3. Preis für "Biomarkers and new therapeutic targets in prostate cancer".
Weitere Infos zur Publikation
23. Mai 2018 - Methods Mol Biol
Culig Z, Santer FR
Studies on Steroid Receptor Coactivators in Prostate Cancer.
Zeige auf PubMed
Zum pdf
17. Mai 2018 - Eur J Nucl Med Mol Imaging
Uprimny C, Svirydenka A, Fritz J, Kroiss AS, Nilica B, Decristoforo C, Haubner R, von Guggenberg E, Buxbaum S, Horninger W, Virgolini IJ
Comparison of [(68)Ga]Ga-PSMA-11 PET/CT with [(18)F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy.
Zeige auf PubMed
Zum pdf
08. Mai 2018 - Cent European J Urol
Lunacek A, Mohamad Al-Ali B, Radmayr C, Weber M, Horninger W, Findl O, Plas E
Ten years of intraoperative floppy iris syndrome in the era of α-blockers.
Zeige auf PubMed
Zum pdf
27. April 2018 - Int J Cancer
Urbiola C, Santer FR, Petersson M, van der Pluijm G, Horninger W, Erlmann P, Wollmann G, Kimpel J, Culig Z, von Laer D
Oncolytic activity of the rhabdovirus VSV-GP against prostate cancer.
Zeige auf PubMed
Zum pdf
18. April 2018 - Int J Rheum Dis
Moosmann T, Veraar C, Brunner J, Fraedrich G, Frech A, Horninger W, Ratzinger G, Streif W, Teuchner B, Willeit J, Zlamy M, De Zordo T, Schirmer M
Differential clinical presentation of Adamantiades-Behçet's disease in non-endemic and endemic areas: retrospective data from a Middle-European cohort study.
Zeige auf PubMed
Zum pdf
13. April 2018 - Transl Androl Urol
Heidegger I, Pichler R, Heidenreich A, Horninger W, Pircher A
Radium-223 for metastatic castration-resistant prostate cancer: results and remaining open issues after the ALSYMPCA trial.
Zeige auf PubMed
Zum pdf
17. März 2018
- I. Eder. Best Abstract Oncology Prize 2018 of the EAU - Third prize for "Upregulation of cholesterol and steroid biosynthesis pathways in prostate cancer cells is associated with diminished response to enzalutamide in a 3-dimensional spheroid co-culture model".
Weitere Infos zur Publikation
15. März 2018 - Oncotarget
Lieb V, Weigelt K, Scheinost L, Fischer K, Greither T, Marcou M, Theil G, Klocker H, Holzhausen HJ, Lai X, Vera J, Ekici AB, Horninger W, Fornara P, Wullich B, Taubert H, Wach S
Serum levels of miR-320 family members are associated with clinical parameters and diagnosis in prostate cancer patients.
Zeige auf PubMed
Zum pdf
03. März 2018 - Cancer Sci
Seeber A, Klinglmair G, Fritz J, Steinkohl F, Zimmer KC, Aigner F, Horninger W, Gastl G, Zelger B, Brunner A, Pichler R
High IDO-1 expression in tumor endothelial cells is associated with response to immunotherapy in metastatic renal cell carcinoma.
Zeige auf PubMed
Zum pdf
22. Februar 2018 - Mol Oncol
Feiersinger GE, Trattnig K, Leitner PD, Guggenberger F, Oberhuber A, Peer S, Hermann M, Skvortsova I, Vrbkova J, Bouchal J, Culig Z, Santer FR
Olaparib is effective in combination with, and as maintenance therapy after, first-line endocrine therapy in prostate cancer cells.
Zeige auf PubMed
Zum pdf
15. Februar 2018 - Int J Cancer
Sampson N, Brunner E, Weber A, Puhr M, Schäfer G, Szyndralewiez C, Klocker H
Inhibition of Nox4-dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal-mediated protumorigenic interactions.
Zeige auf PubMed
Zum pdf
15. Jänner 2018
Aigner, F., Pallwein-Pretter, L., Salomon, G., and Horninger, W. Prostata - Multimodale Bildgebung. Zweite erweiterte Auflage, Horn, Austria, Breitenseher Publisher, 2018.
13. Jänner 2018 - Eur J Med Res
Pichler R, Tulchiner G, Steinkohl F, Soleiman A, Horninger W, Heidegger IM, Aigner F
Adenomatoid tumor of the testis mimicking malignant testicular cancer on multiparametric ultrasound.
Zeige auf PubMed
26. Dezember 2017 - Urol Case Rep
Pichler R, Heidegger I, Schachtner G, Stuehmeier J, Agaimy A, Maier H, Glodny B, Rehder P
Renal rupture - Not what it seems.
Zeige auf PubMed
19. Dezember 2017 - Memo
Pichler R, Heidegger I
Novel concepts of antiangiogenic therapies in metastatic renal cell cancer.
Zeige auf PubMed
19. Dezember 2017 - Front Aging Neurosci
Hoefer J, Luger M, Dal-Pont C, Culig Z, Schennach H, Jochberger S
The "Aging Factor" Eotaxin-1 (CCL11) Is Detectable in Transfusion Blood Products and Increases with the Donor's Age.
Zeige auf PubMed
19. Dezember 2017 - Memo
Haidl F, Pfister D, Heidenreich A, Heidegger I
Antiangiogenic therapies in urogenital malignancies: Fiction or fact?
Zeige auf PubMed
19. Dezember 2017 - Front Immunol
Gruenbacher G, Thurnher M
Mevalonate Metabolism in Immuno-Oncology.
Zeige auf PubMed
16. Dezember 2017 - World J Urol
Steinkohl F, Gruber L, Bektic J, Nagele U, Aigner F, Herrmann TRW, Rieger M, Junker D
Retrospective analysis of the development of PIRADS 3 lesions over time: when is a follow-up MRI reasonable?
Zeige auf PubMed
14. Dezember 2017 - J Cell Biochem
Erb HHH, Guggenberger F, Santer FR, Culig Z
Interleukin-4 induces a CD44(high) /CD49b(high) PC3 subpopulation with tumor-initiating characteristics.
Zeige auf PubMed
08. Dezember 2017 - Curr Mol Biol Rep
Culig Z
Molecular Mechanisms of Enzalutamide Resistance in Prostate Cancer.
Zeige auf PubMed
Zum pdf
28. November 2017 - Curr Eye Res
Waltl I, Zehetner C, Seifarth C, Handle F, Kieselbach GF, Angermann R, Kralinger MT
Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy.
Zeige auf PubMed
22. November 2017 - Clin Cancer Res
Puhr M, Hoefer J, Eigentler A, Ploner C, Handle F, Schaefer G, Kroon J, Leo A, Heidegger I, Eder I, Culig Z, Van der Pluijm G, Klocker H
The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy.
Zeige auf PubMed
21. November 2017 - J Cancer
Pichler R, Fritz J, Heidegger I, Oberaigner W, Horninger W, Hochleitner M
Gender-related Outcome in Bladder Cancer Patients undergoing Radical Cystectomy.
Zeige auf PubMed
20. November 2017
PhD Thesis Medizinische Universität Innsbruck - A. Kohlegger. Perspectives of the chemopreventive effects of natural compoounds in the adjuvant treatment of prostate cancer. Department of Urology, Division of Experimental Urology.
17. November 2017 - Eur J Immunol
Loeschenberger B, Niess L, Würzner R, Schwelberger H, Eder IE, Puhr M, Guenther J, Troppmair J, Rudnicki M, Neuwirt H
Calcineurin inhibitor-induced complement system activation via ERK1/2 signalling is inhibited by SOCS-3 in human renal tubule cells.
Zeige auf PubMed
11. November 2017 - Oncoimmunology
Gruenbacher G, Thurnher M
Mevalonate metabolism governs cancer immune surveillance.
Zeige auf PubMed
01. November 2017 - Int J Mol Sci
Pircher A, Wolf D, Heidenreich A, Hilbe W, Pichler R, Heidegger I
Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality.
Zeige auf PubMed
13. Oktober 2017 - Cell Death Dis
Slabáková E, Culig Z, Remšík J, Souček K
Alternative mechanisms of miR-34a regulation in cancer.
Zeige auf PubMed
Zum pdf
06. Oktober 2017 - Oncotarget
Pichler R, Heidegger I, Fritz J, Danzl M, Sprung S, Zelger B, Brunner A, Pircher A
PD-L1 expression in bladder cancer and metastasis and its influence on oncologic outcome after cystectomy.
Zeige auf PubMed
Zum pdf
02. Oktober 2017 - Clin Genitourin Cancer
Paffenholz P, Heidegger IM, Kuhr K, Loosen SH, Pfister D, Heidenreich A
Non-Guideline-concordant Treatment of Testicular Cancer Is Associated With Reduced Relapse-free Survival.
Zeige auf PubMed
24. September 2017 - BJU Int
Pichler R, Fritz J, Tulchiner G, Klinglmair G, Soleiman A, Horninger W, Klocker H, Heidegger I
Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance.
Zeige auf PubMed
12. September 2017 - Eur Urol
Culig Z
Innovative Therapies to Overcome Resistance to Enzalutamide: Perspective on the Use of Darolutamide.
Zeige auf PubMed
30. August 2017 - Prostate
Shi X, Peng Y, Du X, Liu H, Klocker H, Lin Q, Shi J, Zhang J
Estradiol promotes epithelial-to-mesenchymal transition in human benign prostatic epithelial cells.
Zeige auf PubMed
Zum pdf
22. August 2017 - Int J Med Sci
Pichler R, Tulchiner G, Fritz J, Schaefer G, Horninger W, Heidegger I
Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study.
Zeige auf PubMed
30. Juli 2017 - Eur Urol Focus
Radmayr C, Tekgul S
Paediatric Urology and the Dilemma of Low-quality Evidence for the Management of Common Urological Conditions (Vesicoureteral Reflux, Lower Urinary Tract Dysfunction, Undescended Testis) in Children.
Zeige auf PubMed
24. Juli 2017 - J Pediatr Urol
Radmayr C
Management of undescended testes: European Association of Urology/European Society for Paediatric Urology guidelines.
Zeige auf PubMed
21. Juli 2017 - Eur Urol Focus
Puhr M, De Marzo A, Isaacs W, Lucia MS, Sfanos K, Yegnasubramanian S, Culig Z
Inflammation, Microbiota, and Prostate Cancer.
Zeige auf PubMed
21. Juli 2017 - Eur Urol Focus
Ceder Y, Bjartell A, Culig Z, Rubin MA, Tomlins S, Visakorpi T
The Molecular Evolution of Castration-resistant Prostate Cancer.
Zeige auf PubMed
14. Juli 2017 - Radiologe
Steinkohl F, Luger A, Bektic J, Aigner F
[Ultrasonography of the prostate gland : From B‑image through multiparametric ultrasound to targeted biopsy].
Zeige auf PubMed
28. Juni 2017 - BMC Public Health
Mühlberger N, Boskovic K, Krahn MD, Bremner KE, Oberaigner W, Klocker H, Horninger W, Sroczynski G, Siebert U
Benefits and harms of prostate cancer screening - predictions of the ONCOTYROL prostate cancer outcome and policy model.
Zeige auf PubMed
23. Juni 2017 - Cell Death Dis
Gatliff J, East DA, Singh A, Alvarez MS, Frison M, Matic I, Ferraina C, Sampson N, Turkheimer F, Campanella M
A role for TSPO in mitochondrial Ca(2+) homeostasis and redox stress signaling.
Zeige auf PubMed
22. Juni 2017 - Methods Mol Biol
Eder T, Eder IE
3D Hanging Drop Culture to Establish Prostate Cancer Organoids.
Zeige auf PubMed
Zum pdf
20. Juni 2017 - Radiology
Auer T, De Zordo T, Dejaco C, Gruber L, Pichler R, Jaschke W, Dogra VS, Aigner F
Value of Multiparametric US in the Assessment of Intratesticular Lesions.
Zeige auf PubMed
08. Juni 2017 - Eur J Nucl Med Mol Imaging
Uprimny C, Kroiss AS, Fritz J, Decristoforo C, Kendler D, von Guggenberg E, Nilica B, Maffey-Steffan J, di Santo G, Bektic J, Horninger W, Virgolini IJ
Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence.
Zeige auf PubMed
Zum pdf
13. Juni 2017 - Eur Urol
Heidegger I, Pichler R, Pircher A
Re: Erik Bovinder Ylitalo, Elin Thysell, Emma Jernberg, et al. Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response. Eur Urol 2017;71:776-87.
Zeige auf PubMed
30. Mai 2017 - Oncogenesis
Nappo G, Handle F, Santer FR, McNeill RV, Seed RI, Collins AT, Morrone G, Culig Z, Maitland NJ, Erb HHH
The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signalling.
Zeige auf PubMed
18. Mai 2017 - Urol Int
Heidegger I, Porres D, Veek N, Heidenreich A, Pfister D
Predictive Factors for Developing Venous Thrombosis during Cisplatin-Based Chemotherapy in Testicular Cancer.
Zeige auf PubMed
03. Mai 2017 - J Pediatr Urol
Silay MS, Undre S, Nambiar AK, Dogan HS, Kocvara R, Nijman RJM, Stein R, Tekgul S, Radmayr C
Role of antibiotic prophylaxis in antenatal hydronephrosis: A systematic review from the European Association of Urology/European Society for Paediatric Urology Guidelines Panel.
Zeige auf PubMed
25. April 2017 - Clin Genitourin Cancer
Pichler R, Tulchiner G, Oberaigner W, Schaefer G, Horninger W, Brunner A, Heidegger I
Effect of Urinary Cytology for Detecting Recurrence in Remnant Urothelium After Radical Cystectomy: Insights From a 10-year Cytology Database.
Zeige auf PubMed
26. März 2017 - J Pediatr Urol
Radmayr C, Dogan HS, Hoebeke P, Kocvara R, Nijman R, Silay S, Stein R, Undre S, Tekgul S
Corrigendum to "Management of undescended testes: European Association of Urology/European Society for Paediatric Urology Guidelines" [J Pediatr Urol 12 (2016) 335-343].
Zeige auf PubMed
22. März 2017 - Prostate Cancer Prostatic Dis
Heidegger I, Klocker H, Pichler R, Pircher A, Prokop W, Steiner E, Ladurner C, Comploj E, Lunacek A, Djordjevic D, Pycha A, Plas E, Horninger W, Bektic J
ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer-results from an international multicenter study.
Zeige auf PubMed
20. März 2017 - Mol Cell Endocrinol
Culig Z, Puhr M
Interleukin-6 and prostate cancer: Current developments and unsolved questions.
Zeige auf PubMed
01. Februar 2017 - Eur J Nucl Med Mol Imaging
Uprimny C, Kroiss AS, Decristoforo C, Fritz J, von Guggenberg E, Kendler D, Scarpa L, di Santo G, Roig LG, Maffey-Steffan J, Horninger W, Virgolini IJ
(68)Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour.
Zeige auf PubMed
Zum pdf
31. Jänner 2017 - Mol Oncol
Hanrahan K, O'Neill A, Prencipe M, Bugler J, Murphy L, Fabre A, Puhr M, Culig Z, Murphy K, Watson RW
The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer.
Zeige auf PubMed
Zum pdf
21. Jänner 2017 - Cancer Sci
Pichler R, Fritz J, Heidegger I, Steiner E, Culig Z, Klocker H, Fuchs D
Predictive and prognostic role of serum neopterin and tryptophan breakdown in prostate cancer.
Zeige auf PubMed
Zum pdf
16. Jänner 2017
Horninger, W. Therapieplanung und Therapieüberwachung. In: F. Aigner and L. Pallwein-Pretter (eds.),Prostata - Multimodale Bildgebung, 1. Auflage, Horn, Austria, Breitenseher Publisher, 2016.
14. Jänner 2017 - Eur J Nucl Med Mol Imaging
Scarpa L, Buxbaum S, Kendler D, Fink K, Bektic J, Gruber L, Decristoforo C, Uprimny C, Lukas P, Horninger W, Virgolini I
The (68)Ga/(177)Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUV(max) values and absorbed dose estimates.
Zeige auf PubMed
Zum pdf
23. Dezember 2016 - Cancer Immunol Immunother
Pichler R, Gruenbacher G, Culig Z, Brunner A, Fuchs D, Fritz J, Gander H, Rahm A, Thurnher M
Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer.
Zeige auf PubMed
Zum pdf
14. Dezember 2016 - Urol Oncol
Heidegger I, Oberaigner W, Horninger W, Pichler R
High incidence of clinically significant concomitant prostate cancer in patients undergoing radical cystectomy for bladder cancer: A 10-year single-center experience.
Zeige auf PubMed
Zum pdf
01. Dezember 2016 - Eur J Nucl Med Mol Imaging
Uprimny C, Kroiss AS, Decristoforo C, Fritz J, Warwitz B, Scarpa L, Roig LG, Kendler D, von Guggenberg E, Bektic J, Horninger W, Virgolini IJ
Early dynamic imaging in (68)Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions.
Zeige auf PubMed
Zum pdf
29. November 2016 - J Mol Biochem
Ketola K, Viitala M, Kohonen P, Fey V, Culig Z, Kallioniemi O, Iljin K
High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer.
Zeige auf PubMed
Zum pdf
19. November 2016 - BJU Int
Bauer RM, Grabbert MT, Klehr B, Gebhartl P, Gozzi C, Homberg R, May F, Rehder P, Stief CG, Kretschmer A
36-month data for the AdVance XP(®) male sling: results of a prospective multicentre study.
Zeige auf PubMed
Zum pdf
15. Oktober 2016 - Eur J Med Res
Heidegger I, Tulchiner G, Schäfer G, Horninger W, Pichler R
Long term disease free survival with multimodal therapy in small cell bladder cancer.
Zeige auf PubMed
Zum pdf
01. Oktober 2016 - J Pediatr Urol
Radmayr C, Dogan HS, Hoebeke P, Kocvara R, Nijman R, Silay S, Stein R, Undre S, Tekgul S
Management of undescended testes: European Association of Urology/European Society for Paediatric Urology Guidelines.
Zeige auf PubMed
Zum pdf
08. September 2016 - Clin Genitourin Cancer
Pichler R, De Zordo T, Fritz J, Kroiss A, Aigner F, Heidegger I, Virgolini I, Horninger W, Uprimny C
Pelvic Lymph Node Staging by Combined (18)F-FDG-PET/CT Imaging in Bladder Cancer Prior to Radical Cystectomy.
Zeige auf PubMed
Zum pdf
07. September 2016 - Int J Mol Sci
Eder T, Weber A, Neuwirt H, Grünbacher G, Ploner C, Klocker H, Sampson N, Eder IE
Cancer-Associated Fibroblasts Modify the Response of Prostate Cancer Cells to Androgen and Anti-Androgens in Three-Dimensional Spheroid Culture.
Zeige auf PubMed
Zum pdf
20. August 2016 - Oncotarget
Ippolito L, Marini A, Cavallini L, Morandi A, Pietrovito L, Pintus G, Giannoni E, Schrader T, Puhr M, Chiarugi P, Taddei ML
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells.
Zeige auf PubMed
Zum pdf
12. August 2016 - World J Urol
Auer T, Edlinger M, Bektic J, Nagele U, Herrmann T, Schäfer G, Aigner F, Junker D
Performance of PI-RADS version 1 versus version 2 regarding the relation with histopathological results.
Zeige auf PubMed
Zum pdf
04. August 2016 - Oncotarget
Hoefer J, Akbor M, Handle F, Ofer P, Puhr M, Parson W, Culig Z, Klocker H, Heidegger I
Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamide.
Zeige auf PubMed
Zum pdf
25. Juli 2016 - Clin Genitourin Cancer
Pichler R, Tulchiner G, Aigner F, Horninger W, Heidegger I
Paratesticular Metastasis of a Clear-Cell Renal-Cell Carcinoma With Renal Vein Thrombus Mimicking Primary Testicular Cancer.
Zeige auf PubMed
Zum pdf
28. Juli 2016 - Expert Opin Drug Saf
Pinggera GM, Frauscher F
Do we really need herbal medicine in LUTS/BPH treatment in the 21(st) century?
Zeige auf PubMed
Zum pdf
21. Juli 2016 - Oncotarget
Castelo-Branco P, Leão R, Lipman T, Campbell B, Lee D, Price A, Zhang C, Heidari A, Stephens D, Boerno S, Coelho H, Gomes A, Domingos C, Apolonio JD, Schäfer G, Bristow RG, Schweiger MR, Hamilton R, Zlotta A, Figueiredo A, Klocker H, Sültmann H, Tabori U
A cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: a retrospective cohort study.
Zeige auf PubMed
Zum pdf
20. Juli 2016 - J Pediatr Urol
Haid B, Strasser C, Becker T, Koen M, Berger C, Roesch J, Stuehmeier J, Schlenck B, Horninger W, Oswald J
Evaluation of Mathisen's technique for ureteral reimplantation in children with primary vesicoureteral reflux.
Zeige auf PubMed
Zum pdf
13. Juli 2016 - Eur Urol
Culig Z
STAT3 in Prostate Cancer: Whom Should We Treat and When?
Zeige auf PubMed
Zum pdf
29. Juni 2016 - Cytokine
Pencik J, Pham HT, Schmoellerl J, Javaheri T, Schlederer M, Culig Z, Merkel O, Moriggl R, Grebien F, Kenner L
JAK-STAT signaling in cancer: From cytokines to non-coding genome.
Zeige auf PubMed
Zum pdf
28. Juni 2016 - Cell Rep
Gruenbacher G, Gander H, Rahm A, Idzko M, Nussbaumer O, Thurnher M
Ecto-ATPase CD39 Inactivates Isoprenoid-Derived Vγ9Vδ2 T Cell Phosphoantigens.
Zeige auf PubMed
Zum pdf
25. Juni 2016 - Cell Chem Biol
Thurnher M
Small Drops Get Fat: Unexpected Fatty Acid in Cytoplasmic Lipid Droplets.
Zeige auf PubMed
Zum pdf
17. Juni 2016 - Mol Cell Oncol
Culig Z, Pencik J, Merkel O, Kenner L
Breaking a paradigm: IL-6/STAT3 signaling suppresses metastatic prostate cancer upon ARF expression.
Zeige auf PubMed
Zum pdf
04. Juni 2016 - Endocr Relat Cancer
Luef B, Handle F, Kharaishvili G, Hager M, Rainer J, Janetschek G, Hruby S, Englberger C, Bouchal J, Santer FR, Culig Z
The AR/NCOA1 axis regulates prostate cancer migration by involvement of PRKD1.
Zeige auf PubMed
Zum pdf
27. Mai 2016 - Oncoscience
Boesch M, Zeimet AG, Fiegl H, Wolf B, Huber J, Klocker H, Gastl G, Sopper S, Wolf D
High prevalence of side population in human cancer cell lines.
Zeige auf PubMed
26. Mai 2016 - Oncotarget
Pichler R, Fritz J, Zavadil C, Schäfer G, Culig Z, Brunner A
Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Guérin therapy in bladder cancer.
Zeige auf PubMed
Zum pdf
11. Mai 2016 - Endocrinology
Jia B, Gao Y, Li M, Shi J, Peng Y, Du X, Klocker H, Sampson N, Shen Y, Liu M, Zhang J
GPR30 Promotes Prostate Stromal Cell Activation via Suppression of ERα Expression and Its Downstream Signaling Pathway.
Zeige auf PubMed
17. April 2016 - Nucleic Acids Res
Weissensteiner H, Forer L, Fuchsberger C, Schöpf B, Kloss-Brandstätter A, Specht G, Kronenberg F, Schönherr S
mtDNA-Server: next-generation sequencing data analysis of human mitochondrial DNA in the cloud.
Zeige auf PubMed
Zum pdf
10. April 2016 - FEBS J
Schöpf B, Schäfer G, Weber A, Talasz H, Eder IE, Klocker H, Gnaiger E
Oxidative phosphorylation and mitochondrial function differ between human prostate tissue and cultured cells.
Zeige auf PubMed
08. April 2016 - Mol Cancer Res
Handle F, Erb HH, Luef B, Hoefer J, Dietrich D, Parson W, Kristiansen G, Santer FR, Culig Z
SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells.
Zeige auf PubMed
Zum pdf
07. April 2016 - Rofo
Auer T, De Zordo T, Horninger W, Jaschke W, Aigner F
[Multiparametric US of the Testicles--Selected Cases].
Zeige auf PubMed
Zum pdf
30. März 2016 - Adv Urol
Rehder P, Staudacher NM, Schachtner J, Berger ME, Schillfahrt F, Hauser V, Mueller R, Skradski V, Horninger W, Glodny B
Hypothesis That Urethral Bulb (Corpus Spongiosum) Plays an Active Role in Male Urinary Continence.
Zeige auf PubMed
Zum pdf
19. März 2016 - Mol Oncol
Kurfurstova D, Bartkova J, Vrtel R, Mickova A, Burdova A, Majera D, Mistrik M, Kral M, Santer FR, Bouchal J, Bartek J
DNA damage signalling barrier, oxidative stress and treatment-relevant DNA repair factor alterations during progression of human prostate cancer.
Zeige auf PubMed
Zum pdf
10. März 2016 - Oncotarget
Pircher A, Jöhrer K, Kocher F, Steiner N, Graziadei I, Heidegger I, Pichler R, Leonhartsberger N, Kremser C, Kern J, Untergasser G, Gunsilius E, Hilbe W
Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies.
Zeige auf PubMed
Zum pdf
13. März 2016 - BJU Int
Culig Z
New possibilities for urinary molecular diagnostics.
Zeige auf PubMed
Zum pdf
08. April 2016 - Mol Cancer Res
Handle F, Erb HH, Luef B, Hoefer J, Dietrich D, Parson W, Kristiansen G, Santer FR, Culig Z
SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells.
Zeige auf PubMed
Zum pdf
17. Oktober 2015 - Urologe A
Pichler R, Horninger W, Aigner F, Heidegger I
[Bevacizumab as first-line therapy in metastatic renal cell carcinoma: Progression-free survival for 3 years].
Zeige auf PubMed
Zum pdf
30. März 2016 - Adv Urol
Rehder P, Staudacher NM, Schachtner J, Berger ME, Schillfahrt F, Hauser V, Mueller R, Skradski V, Horninger W, Glodny B
Hypothesis That Urethral Bulb (Corpus Spongiosum) Plays an Active Role in Male Urinary Continence.
Zeige auf PubMed
Zum pdf
11. Februar 2016 - PLoS One
Schlick B, Massoner P, Lueking A, Charoentong P, Blattner M, Schaefer G, Marquart K, Theek C, Amersdorfer P, Zielinski D, Kirchner M, Trajanoski Z, Rubin MA, Müllner S, Schulz-Knappe P, Klocker H
Serum Autoantibodies in Chronic Prostate Inflammation in Prostate Cancer Patients.
Zeige auf PubMed
Zum pdf
03. Februar 2016 - Wien Klin Wochenschr
Ponholzer A, Loidl W, Bektic J, Dorfinger K, Hruby S, Jeschke K, Kramer G, Krause S, Ludvik G, Remzi M, Roider M, Stoiber F
Austrian recommendations on Targeted Hormone Therapy for metastatic, castration-resistant prostate cancer.
Zeige auf PubMed
Zum pdf
06. Jänner 2016 - BMJ Open
Schönherr E, Rehwald R, Nasseri P, Luger AK, Grams AE, Kerschbaum J, Rehder P, Petersen J, Glodny B
Retrospective morphometric study of the suitability of renal arteries for renal denervation according to the Symplicity HTN2 trial criteria.
Zeige auf PubMed
Zum pdf
23. Dezember 2015 - Swiss Med Wkly
Pencik J, Wiebringhaus R, Susani M, Culig Z, Kenner L
IL-6/STAT3/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancer.
Zeige auf PubMed
Zum pdf
20. November 2015 - World J Urol
Bauer RM, Gozzi C, Klehr B, Kretschmer A, Grabbert M, Rehder P, May F, Stief CG, Gebhartl P, Homberg R
AdVanceXP male sling: 2-year results of a multicentre study.
Zeige auf PubMed
Zum pdf
17. November 2015 - Urol Int
Heidegger I, Fritz J, Steiner H, Bektic J, Pichler R
Hydronephrosis Predicts Successful Catheter Removal after Painful Urinary Retention - Preliminary Results of a Prospective Single Center Study.
Zeige auf PubMed
Zum pdf
21. Oktober 2015 - Endocr Relat Cancer
Kroon J, Puhr M, Buijs JT, van der Horst G, Hemmer DM, Marijt KA, Hwang MS, Masood M, Grimm S, Storm G, Metselaar JM, Meijer OC, Culig Z, van der Pluijm G
Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.
Zeige auf PubMed
Zum pdf
17. Oktober 2015 - Urologe A
Pichler R, Horninger W, Aigner F, Heidegger I
[Bevacizumab as first-line therapy in metastatic renal cell carcinoma: Progression-free survival for 3 years].
Zeige auf PubMed
10. Oktober 2015 - Mol Endocrinol
Ofer P, Heidegger I, Eder IE, Schöpf B, Neuwirt H, Geley S, Klocker H, Massoner P
Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In Vivo.
Zeige auf PubMed
Zum pdf
30. September 2015 - Oncotarget
Slabáková E, Kharaishvili G, Smějová M, Pernicová Z, Suchánková T, Remšík J, Lerch S, Straková N, Bouchal J, Král M, Culig Z, Kozubík A, Souček K
Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells.
Zeige auf PubMed
Zum pdf
29. September 2015 - Hum Mutat
Bu H, Narisu N, Schlick B, Rainer J, Manke T, Schäfer G, Pasqualini L, Chines P, Schweiger MR, Fuchsberger C, Klocker H
Putative Prostate Cancer Risk SNP in an Androgen Receptor-Binding Site of the Melanophilin Gene Illustrates Enrichment of Risk SNPs in Androgen Receptor Target Sites.
Zeige auf PubMed
Zum pdf
02. September 2015 - Oncotarget
Perner S, Cronauer MV, Schrader AJ, Klocker H, Culig Z, Baniahmad A
Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer.
Zeige auf PubMed
Zum pdf
27. August 2015 - Prostate
Heidegger I, Höfer J, Luger M, Pichler R, Klocker H, Horninger W, Steiner E, Jochberger S, Culig Z
Is Eotaxin-1 a serum and urinary biomarker for prostate cancer detection and recurrence?
Zeige auf PubMed
Zum pdf
20. August 2015
Semin Cancer Biol.
19. August 2015 - PLoS One
Dueregger A, Schöpf B, Eder T, Höfer J, Gnaiger E, Aufinger A, Kenner L, Perktold B, Ramoner R, Klocker H, Eder IE
Differential Utilization of Dietary Fatty Acids in Benign and Malignant Cells of the Prostate.
Zeige auf PubMed
12. Juni 2015 - Stud Health Technol Inform
Hofer P, Neururer S, Hauffe H, Insam T, Zeilner A, Göbel G
Semi-automated evaluation of biomedical ontologies for the biobanking domain based on competency questions.
Zeige auf PubMed
Zum pdf
12. August 2015 - PLoS One
Kloss-Brandstätter A, Weissensteiner H, Erhart G, Schäfer G, Forer L, Schönherr S, Pacher D, Seifarth C, Stöckl A, Fendt L, Sottsas I, Klocker H, Huck CW, Rasse M, Kronenberg F, Kloss FR
Validation of Next-Generation Sequencing of Entire Mitochondrial Genomes and the Diversity of Mitochondrial DNA Mutations in Oral Squamous Cell Carcinoma.
Zeige auf PubMed
Zum pdf
11. August 2015 - Oncogene
Puhr M, Hoefer J, Eigentler A, Dietrich D, van Leenders G, Uhl B, Hoogland M, Handle F, Schlick B, Neuwirt H, Sailer V, Kristiansen G, Klocker H, Culig Z
PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer.
Zeige auf PubMed
Zum pdf
02. August 2015 - Cancer Lett
Heidegger I, Massoner P, Sampson N, Klocker H
The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer.
Zeige auf PubMed
Zum pdf
29. Juli 2015 - PLoS One
Heidegger I, Fritz J, Klocker H, Pichler R, Bektic J, Horninger W
Age-Adjusted PSA Levels in Prostate Cancer Prediction: Updated Results of the Tyrol Prostate Cancer Early Detection Program.
Zeige auf PubMed
Zum pdf
24. Juli 2015 - J Cell Physiol
Culig Z
Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer.
Zeige auf PubMed
Zum pdf
02. Juli 2015 - World J Urol
Junker D, Herrmann TR, Bader M, Bektic J, Henkel G, Kruck S, Sandbichler M, Schilling D, Schäfer G, Nagele U, Training Research in Urological Surgery Therapy (T.R.U.S.T.) group
Evaluation of the 'Prostate Interdisciplinary Communication and Mapping Algorithm for Biopsy and Pathology' (PIC-MABP).
Zeige auf PubMed
Zum pdf
09. Juni 2015 - Mol Endocrinol
Pasqualini L, Bu H, Puhr M, Narisu N, Rainer J, Schlick B, Schäfer G, Angelova M, Trajanoski Z, Börno ST, Schweiger MR, Fuchsberger C, Klocker H
miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer.
Zeige auf PubMed
Zum pdf
31. Mai 2015 - Anticancer Res
Heidegger I, Klocker H, Pichler R, Horninger W, Bektic J
PSA Isoforms' Velocities for Early Diagnosis of Prostate Cancer.
Zeige auf PubMed
Zum pdf
16. Mai 2015 - Med Decis Making
Mühlberger N, Kurzthaler C, Iskandar R, Krahn MD, Bremner KE, Oberaigner W, Klocker H, Horninger W, Conrads-Frank A, Sroczynski G, Siebert U
The ONCOTYROL Prostate Cancer Outcome and Policy Model: Effect of Prevalence Assumptions on the Benefit-Harm Balance of Screening.
Zeige auf PubMed
Zum pdf
16. Mai 2015 - Eur J Nucl Med Mol Imaging
Ceci F, Uprimny C, Nilica B, Geraldo L, Kendler D, Kroiss A, Bektic J, Horninger W, Lukas P, Decristoforo C, Castellucci P, Fanti S, Virgolini IJ
(68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
Zeige auf PubMed
Zum pdf
13. Mai 2015 - Anticancer Res
Heidegger I, Borena W, Pichler R
The role of human papilloma virus in urological malignancies.
Zeige auf PubMed
Zum pdf
16. April 2015 - EMBO Mol Med
Meidhof S, Brabletz S, Lehmann W, Preca BT, Mock K, Ruh M, Schüler J, Berthold M, Weber A, Burk U, Lübbert M, Puhr M, Culig Z, Wellner U, Keck T, Bronsert P, Küsters S, Hopt UT, Stemmler MP, Brabletz T
ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat.
Zeige auf PubMed
Zum pdf
02. April 2015 - Sci Signal
Thurnher M, Gruenbacher G
T lymphocyte regulation by mevalonate metabolism.
Zeige auf PubMed
Zum pdf
25. März 2015 - Biomed Res Int
Herwig R, Sansalone S, Rehder P
Genitourethral reconstruction.
Zeige auf PubMed
Zum pdf
20. März 2015 - World J Urol
Pichler R, Borena W, Schäfer G, Manzl C, Culig Z, List S, Neururer S, Von Laer D, Heidegger I, Klocker H, Horninger W, Steiner H, Brunner A
Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blot.
Zeige auf PubMed
Zum pdf
10. März 2015 - Oncotarget
Santer FR, Erb HH, Oh SJ, Handle F, Feiersinger GE, Luef B, Bu H, Schäfer G, Ploner C, Egger M, Rane JK, Maitland NJ, Klocker H, Eder IE, Culig Z
Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy.
Zeige auf PubMed
Zum pdf
06. März 2015
C. Radmayr, C. Congenital obstructive uropathy - Diagnostics for optimal treatment. Afr J Urol 21:87-95, 2015.
14. Februar 2015 - PLoS One
Neuwirt H, Wabnig E, Feistritzer C, Eder IE, Salvador C, Puhr M, Culig Z, Massoner P, Tiefenthaler M, Steurer M, Konwalinka G
Akacid medical formulation induces apoptosis in myeloid and lymphatic leukemic cell lines in vitro and in vivo.
Zeige auf PubMed
Zum pdf
10. Februar 2015 - Urol Int
Geiger-Gritsch S, Oberaigner W, Mühlberger N, Siebert U, Ladurner M, Klocker H, Horninger W
Patient-reported urinary incontinence and erectile dysfunction following radical prostatectomy: results from the European Prostate Centre Innsbruck.
Zeige auf PubMed
Zum pdf
07. Februar 2015 - PLoS One
Heidegger I, Skradski V, Steiner E, Klocker H, Pichler R, Pircher A, Horninger W, Bektic J
High risk of under-grading and -staging in prostate cancer patients eligible for active surveillance.
Zeige auf PubMed
Zum pdf
17. Jänner 2015 - Urol Int
Junker D, Schäfer G, Heidegger I, Bektic J, Ladurner M, Jaschke W, Aigner F
Multiparametric magnetic resonance imaging/transrectal ultrasound fusion targeted biopsy of the prostate: preliminary results of a prospective single-centre study.
Zeige auf PubMed
Zum pdf
07. Jänner 2015 - Mol Carcinog
Höll M, Koziel R, Schäfer G, Pircher H, Pauck A, Hermann M, Klocker H, Jansen-Dürr P, Sampson N
ROS signaling by NADPH oxidase 5 modulates the proliferation and survival of prostate carcinoma cells.
Zeige auf PubMed
Zum pdf
28. Dezember 2014 - Jpn J Clin Oncol
Pircher A, Gastl G, Heidegger I
Ulcerative skin metastases of primary lung cancer.
Zeige auf PubMed
Zum pdf
06. Dezember 2014 - Eur Urol
Stein R, Dogan HS, Hoebeke P, Kočvara R, Nijman RJ, Radmayr C, Tekgül S, European Association of Urology, European Society for Pediatric Urology
Urinary tract infections in children: EAU/ESPU guidelines.
Zeige auf PubMed
Zum pdf
05. Dezember 2014 - Oncotarget
Puhr M, Hoefer J, Neuwirt H, Eder IE, Kern J, Schäfer G, Geley S, Heidegger I, Klocker H, Culig Z
PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells.
Zeige auf PubMed
Zum pdf
03. Dezember 2014 - J Urol
Culig Z
Epithelial-to-mesenchymal transition in a virally induced cancer.
Zeige auf PubMed
Zum pdf
28. Jänner 2016 - Transl Androl Urol
Kaya C, Radmayr C
The role of pre-operative androgen stimulation in hypospadias surgery.
Zeige auf PubMed
Zum pdf
07. November 2014 - Biomed Res Int
Haubner R, Maschauer S, Einsiedel J, Eder IE, Rangger C, Gmeiner P, Virgolini IJ, Prante O
H-CRRETAWAC-OH, a lead structure for the development of radiotracer targeting integrin α5β1?
Zeige auf PubMed
Zum pdf
07. November 2014 - Am J Clin Exp Urol
Culig Z
Proinflammatory cytokine interleukin-6 in prostate carcinogenesis.
Zeige auf PubMed
Zum pdf
23. Oktober 2014 - Nutrients
Dueregger A, Heidegger I, Ofer P, Perktold B, Ramoner R, Klocker H, Eder IE
The use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatment.
Zeige auf PubMed
Zum pdf
23. Oktober 2013 - World J Urol
Heidegger I, Pichler R, Müller B, Klocker H, Oswald D, Haid B, Zelger B, Horninger W, Oswald J
Is real-time PCR the correct method to evaluate the incidence of human papillomavirus in prepuces of asymptomatic boys and men?
Zeige auf PubMed
Zum pdf
09. Oktober 2014 - Eur J Nucl Med Mol Imaging
Uprimny C, Kroiss A, Nilica B, Buxbaum S, Decristoforo C, Horninger W, Virgolini IJ
(68)Ga-PSMA ligand PET versus (18)F-NaF PET: evaluation of response to (223)Ra therapy in a prostate cancer patient.
Zeige auf PubMed
Zum pdf
05. Oktober 2014 - Lancet Oncol
Cuzick J, Thorat MA, Andriole G, Brawley OW, Brown PH, Culig Z, Eeles RA, Ford LG, Hamdy FC, Holmberg L, Ilic D, Key TJ, La Vecchia C, Lilja H, Marberger M, Meyskens FL, Minasian LM, Parker C, Parnes HL, Perner S, Rittenhouse H, Schalken J, Schmid HP, Schmitz-Dräger BJ, Schröder FH, Stenzl A, Tombal B, Wilt TJ, Wolk A
Prevention and early detection of prostate cancer.
Zeige auf PubMed
Zum pdf
27. September 2014 - Case Rep Urol
Rehder P, Schillfahrt F, Skradski V
Surgical reconstruction of the urinary sphincter after traumatic longitudinal disruption.
Zeige auf PubMed
Zum pdf
20. September 2014 - Oncotarget
Neeb A, Hefele S, Bormann S, Parson W, Adams F, Wolf P, Miernik A, Schoenthaler M, Kroenig M, Wilhelm K, Schultze-Seemann W, Nestel S, Schaefer G, Bu H, Klocker H, Nazarenko I, Cato AC
Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer.
Zeige auf PubMed
Zum pdf
28. August 2014 - Stud Health Technol Inform
Hofer P, Fiegl H, Angerer J, Mueller-Holzner E, Chamson M, Klocker H, Steiner E, Hauffe H, Zschocke J, Goebel G
A concept of a MIABIS based register of biosample collections at the Medical University of Innsbruck.
Zeige auf PubMed
Zum pdf
21. August 2014 - Cent European J Urol
Lunacek A, Radmayr C, Horninger W, Plas E
Pfannenstiel incision for radical retropubic prostatectomy as a surgical and cosmetic alternative to the midline or laparoscopic approach: A single center study.
Zeige auf PubMed
Zum pdf
14. August 2014 - Urol Int
Pichler R, Heidegger I, Aigner F, Bösmüller C, Schneeberger S, Maglione M, Schäfer G, Steiner H, Horninger W
De novo renal cell carcinoma in a kidney allograft with focus on contrast-enhanced ultrasound.
Zeige auf PubMed
Zum pdf
08. August 2014 - Int J Urol
Lunacek A, Mrstik C, Simon J, Frauscher F, Schwentner C, Radmayr C, Horninger W, Plas E
Response to Editorial Comment to Combination of lidocaine suppository and periprostatic nerve block during transrectal prostate biopsy: a prospective randomized trial.
Zeige auf PubMed
Zum pdf
05. August 2014 - Clin Genitourin Cancer
Pichler R, Heidegger I, Brunner A, Steiner H
Long-term follow-up of a primary teratoma with somatic-type malignancy within the thyroid gland mimicking thyroid carcinoma.
Zeige auf PubMed
Zum pdf
02. August 2014 - World J Urol
Junker D, Quentin M, Nagele U, Edlinger M, Richenberg J, Schaefer G, Ladurner M, Jaschke W, Horninger W, Aigner F
Evaluation of the PI-RADS scoring system for mpMRI of the prostate: a whole-mount step-section analysis.
Zeige auf PubMed
Zum pdf
04. Juli 2014 - Br J Cancer
Massoner P, Thomm T, Mack B, Untergasser G, Martowicz A, Bobowski K, Klocker H, Gires O, Puhr M
EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205.
Zeige auf PubMed
Zum pdf
01. Juli 2014 - Int J Urol
Lunacek A, Mrstik C, Simon J, Frauscher F, Schwentner C, Radmayr C, Horninger W, Plas E
Combination of lidocaine suppository and periprostatic nerve block during transrectal prostate biopsy: a prospective randomized trial.
Zeige auf PubMed
Zum pdf
28. Juni 2014 - Urol Int
Comploj E, West J, Mian M, Kluth LA, Karl A, Dechet C, Shariat SF, Stief CG, Trenti E, Palermo S, Lodde M, Horninger W, Madersbacher S, Pycha A
Comparison of complications from radical cystectomy between old-old versus oldest-old patients.
Zeige auf PubMed
Zum pdf
27. Juni 2014 - Biomed Res Int
Junker D, De Zordo T, Quentin M, Ladurner M, Bektic J, Horniger W, Jaschke W, Aigner F
Real-time elastography of the prostate.
Zeige auf PubMed
Zum pdf
19. Juni 2014 - Urology
Pinggera GM, Frauscher F, Paduch DA, Bolyakov A, Efros M, Kaminetsky J, Da Pozzo L, Esler A, Cox D
Effect of tadalafil once daily on prostate blood flow and perfusion in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a randomized, double-blind, multicenter, placebo-controlled trial.
Zeige auf PubMed
Zum pdf
11. Juni 2014 - Mol Cancer
Köhler A, Demir U, Kickstein E, Krauss S, Aigner J, Aranda-Orgillés B, Karagiannidis AI, Achmüller C, Bu H, Wunderlich A, Schweiger MR, Schaefer G, Schweiger S, Klocker H, Schneider R
A hormone-dependent feedback-loop controls androgen receptor levels by limiting MID1, a novel translation enhancer and promoter of oncogenic signaling.
Zeige auf PubMed
Zum pdf
04. Juni 2014 - Expert Opin Pharmacother
Culig Z
Targeting the androgen receptor in prostate cancer.
Zeige auf PubMed
Zum pdf
29. Mai 2014 - Korean J Urol
Lunacek A, Koenig U, Mrstik C, Radmayr C, Horninger W, Plas E
Unexpected Multidrug Resistance of Methicillin-Resistant Staphylococcus aureus in Urine Samples: A Single-Center Study.
Zeige auf PubMed
Zum pdf
10. Mai 2014 - Oncotarget
Heidegger I, Kern J, Ofer P, Klocker H, Massoner P
Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis.
Zeige auf PubMed
Zum pdf
29. April 2014 - Eur Urol
Culig Z
TMPRSS:ERG fusion in prostate cancer: from experimental approaches to prognostic studies.
Zeige auf PubMed
Zum pdf
25. April 2014 - Endocrine
Ning Z, Du X, Zhang J, Yang K, Miao L, Zhu Y, Yuan H, Wang L, Klocker H, Shi J
PGE2 modulates the transcriptional activity of ERRa in prostate stromal cells.
Zeige auf PubMed
Zum pdf
23. April 2014 - Prostate
Shao R, Shi J, Liu H, Shi X, Du X, Klocker H, Lee C, Zhu Y, Zhang J
Epithelial-to-mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia.
Zeige auf PubMed
Zum pdf
05. April 2014 - Biomed Res Int
Sampson N, Berger P, Zenzmaier C
Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic disease.
Zeige auf PubMed
Zum pdf
01. April 2014 - Scand J Urol
Pichler R, Heidegger I, Schlenck B, Horninger W, Oswald J
Clinical outcome after endoscopic therapy for occult vesicoureteral reflux in females: preliminary results of a retrospective case series.
Zeige auf PubMed
22. März 2014 - Int J Urol
Heidegger I, Pichler R, Schäfer G, Zelger B, Zelger B, Aigner F, Bektic J, Horninger W
Long-term follow up of renal anastomosing hemangioma mimicking renal angiosarcoma.
Zeige auf PubMed
Zum pdf
21. März 2014 - Eur Urol
Culig Z
Words of wisdom: Re: TMPRSS2-ERG gene fusions induce prostate tumorigenesis by modulating microRNA miR-200c.
Zeige auf PubMed
Zum pdf
21. März 2014 - Eur Urol
Culig Z
Words of wisdom: Re: Lin28 promotes growth of prostate cancer cells and activates the androgen receptor.
Zeige auf PubMed
Zum pdf
26. Februar 2014 - Eur Urol
Sampson N, Berger P, Klocker H
Re: Delila Gasi Tandefelt, Joost L. Boormans, Hetty A. van der Korput, Guido W. Jenster, Jan Trapman. A 36-gene signature predicts clinical progression in a subgroup of ERG-positive prostate cancers. Eur Urol 2013;64:941-50.
Zeige auf PubMed
Zum pdf
25. Februar 2014 - Urology
Leonhartsberger N, Pichler R, Stoehr B, Horninger W, Steiner H
Organ preservation technique without ischemia in patients with testicular tumor.
Zeige auf PubMed
Zum pdf
22. Februar 2014 - AJR Am J Roentgenol
Junker D, Schäfer G, Kobel C, Kremser C, Bektic J, Jaschke W, Aigner F
Comparison of real-time elastography and multiparametric MRI for prostate cancer detection: a whole-mount step-section analysis.
Zeige auf PubMed
Zum pdf
18. Februar 2014 - Recent Results Cancer Res
Culig Z
Distinguishing indolent from aggressive prostate cancer.
Zeige auf PubMed
04. Februar 2014 - BMC Cancer
Demir U, Koehler A, Schneider R, Schweiger S, Klocker H
Metformin anti-tumor effect via disruption of the MID1 translational regulator complex and AR downregulation in prostate cancer cells.
Zeige auf PubMed
Zum pdf
29. Jänner 2014 - Cancer Lett
Gruenbacher G, Thurnher M
Mevalonate metabolism in cancer.
Zeige auf PubMed
Zum pdf
10. Jänner 2014 - Anticancer Res
Heidegger I, Nagele U, Pircher A, Pichler R, Horninger W, Bektic J
Latent hypothyreosis as a clinical biomarker for therapy response under abiraterone acetate therapy.
Zeige auf PubMed
Zum pdf
10. Jänner 2014 - Oncology
Pircher A, Wellbrock J, Fiedler W, Heidegger I, Gunsilius E, Hilbe W
New antiangiogenic strategies beyond inhibition of vascular endothelial growth factor with special focus on axon guidance molecules.
Zeige auf PubMed
Zum pdf
08. Jänner 2014 - Biomed Res Int
Junker D, Schäfer G, Edlinger M, Kremser C, Bektic J, Horninger W, Jaschke W, Aigner F
Evaluation of the PI-RADS scoring system for classifying mpMRI findings in men with suspicion of prostate cancer.
Zeige auf PubMed
Zum pdf
04. Jänner 2014 - Cancer Metastasis Rev
Culig Z, Santer FR
Androgen receptor signaling in prostate cancer.
Zeige auf PubMed
Zum pdf
04. Dezember 2013 - Urology
Oswald J, Heidegger I, Steiner E, Brenner E, Ladurner Rennau M, Pichler R, Becker T, Loidl W, Horninger W, Fritsch H
Gender-related fetal development of the internal urethral sphincter.
Zeige auf PubMed
28. November 2013 - Endocr Relat Cancer
Hoefer J, Kern J, Ofer P, Eder IE, Schäfer G, Dietrich D, Kristiansen G, Geley S, Rainer J, Gunsilius E, Klocker H, Culig Z, Puhr M
SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.
Zeige auf PubMed
30. Oktober 2013 - World J Urol
Comploj E, Dechet CB, Mian M, Trenti E, Palermo S, Lodde M, Mian C, Ambrosini-Spaltro A, Horninger W, Pycha A
Perforation during TUR of bladder tumours influences the natural history of superficial bladder cancer.
Zeige auf PubMed
30. Oktober 2013 - Prostate Cancer Prostatic Dis
Heidegger I, Klocker H, Steiner E, Skradski V, Ladurner M, Pichler R, Schäfer G, Horninger W, Bektic J
[-2]proPSA is an early marker for prostate cancer aggressiveness.
Zeige auf PubMed
16. Jänner 2014 - Cancer Metastasis Rev
Augello MA, Den RB, Knudsen KE
AR function in promoting metastatic prostate cancer.
Zeige auf PubMed
Zum pdf
23. Oktober 2013 - World J Urol
Heidegger I, Pichler R, Müller B, Klocker H, Oswald D, Haid B, Zelger B, Horninger W, Oswald J
Is real-time PCR the correct method to evaluate the incidence of human papillomavirus in prepuces of asymptomatic boys and men?
Zeige auf PubMed
05. Oktober 2013 - World J Urol
Leonhartsberger N, Pichler R, Stoehr B, Horninger W, Steiner H
Organ-sparing surgery is the treatment of choice in benign testicular tumors.
Zeige auf PubMed
Zum pdf
18. September 2013 - Biomed Tech (Berl)
Popovscaia M, Baumgartner C, Handler M, Klocker H
Identifying Biologically Meaningful Groups of Genes in the Androgen Receptor Network.
Zeige auf PubMed
Zum pdf
27. August 2013 - Phytomedicine
Dueregger A, Guggenberger F, Barthelmes J, Stecher G, Schuh M, Intelmann D, Abel G, Haunschild J, Klocker H, Ramoner R, Sampson N
Attenuation of nucleoside and anti-cancer nucleoside analog drug uptake in prostate cancer cells by Cimicifuga racemosa extract BNO-1055.
Zeige auf PubMed
Zum pdf
20. August 2013 - J Proteomics
Pallua JD, Schaefer G, Seifarth C, Becker M, Meding S, Rauser S, Walch A, Handler M, Netzer M, Popovscaia M, Osl M, Baumgartner C, Lindner H, Kremser L, Sarg B, Bartsch G, Huck CW, Bonn GK, Klocker H
MALDI-MS tissue imaging identification of biliverdin reductase B overexpression in prostate cancer.
Zeige auf PubMed
Zum pdf
06. August 2013 - Endocr Relat Cancer
Erb HH, Langlechner RV, Moser PL, Handle F, Casneuf T, Verstraeten K, Schlick B, Schäfer G, Hall B, Sasser K, Culig Z, Santer FR
IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα2 through IRF9.
Zeige auf PubMed
Zum pdf
25. Juni 2013 - J Immunol
Nussbaumer O, Gruenbacher G, Gander H, Komuczki J, Rahm A, Thurnher M
Essential requirements of zoledronate-induced cytokine and γδ T cell proliferative responses.
Zeige auf PubMed
Zum pdf
Kurzinformation
25. Juni 2013 - J Steroid Biochem Mol Biol
Heidegger I, Massoner P, Eder IE, Pircher A, Pichler R, Aigner F, Bektic J, Horninger W, Klocker H
Novel therapeutic approaches for the treatment of castration-resistant prostate cancer.
Zeige auf PubMed
Zum pdf
14. Juni 2013 - Eur Urol
Barbieri CE, Bangma CH, Bjartell A, Catto JW, Culig Z, Grönberg H, Luo J, Visakorpi T, Rubin MA
The mutational landscape of prostate cancer.
Zeige auf PubMed
Zum pdf
06. Juni 2013 - Urol Int
Pichler R, Heidegger I, Klinglmair G, Kroiss A, Uprimny C, Gasser RW, Schäfer G, Steiner H
Unrecognized paraganglioma of the urinary bladder as a cause for basilar-type migraine.
Zeige auf PubMed
Zum pdf
06. Juni 2013 - Int J Mol Sci
Eder IE, Egger M, Neuwirt H, Seifarth C, Maddalo D, Desiniotis A, Schäfer G, Puhr M, Bektic J, Cato AC, Klocker H
Enhanced inhibition of prostate tumor growth by dual targeting the androgen receptor and the regulatory subunit type iα of protein kinase a in vivo.
Zeige auf PubMed
Zum pdf
18. Mai 2013 - Tech Coloproctol
Plaikner M, Loizides A, Peer S, Aigner F, Pecival D, Zbar A, Kremser C, Gruber H
Transperineal ultrasonography as a complementary diagnostic tool in identifying acute perianal sepsis.
Zeige auf PubMed
Zum pdf
07. Mai 2013 - Steroids
Culig Z, Santer FR
Molecular aspects of androgenic signaling and possible targets for therapeutic intervention in prostate cancer.
Zeige auf PubMed
Zum pdf
13. April 2013 - Endocr Relat Cancer
Wu X, Gong S, Roy-Burman P, Lee P, Culig Z
Current mouse and cell models in prostate cancer research.
Zeige auf PubMed
Zum pdf
13. April 2013 - Fertil Steril
Frühmesser A, Vogt PH, Zimmer J, Witsch-Baumgartner M, Fauth C, Zschocke J, Pinggera GM, Kotzot D
Single nucleotide polymorphism array analysis in men with idiopathic azoospermia or oligoasthenozoospermia syndrome.
Zeige auf PubMed
Zum pdf
05. April 2013 - Transfusion
Gassner C, Utz I, Schennach H, Ramoni A, Steiner H, Scholz S, Kreklau U, Körmöczi GF
Novel RHD alleles with weak hemagglutination and genetic Exon 9 diversity: weak D Types 45.1, 75, and 76.
Zeige auf PubMed
Zum pdf
26. März 2013 - Biochim Biophys Acta
Thurnher M, Gruenbacher G, Nussbaumer O
Regulation of mevalonate metabolism in cancer and immune cells.
Zeige auf PubMed
Zum pdf
Kurzinformation
16. März 2013 - Cancer Cytopathol
Comploj E, Mian C, Ambrosini-Spaltro A, Dechet C, Palermo S, Trenti E, Lodde M, Horninger W, Pycha A
uCyt+/ImmunoCyt and cytology in the detection of urothelial carcinoma: an update on 7422 analyses.
Zeige auf PubMed
Zum pdf
09. März 2013 - BJU Int
Pichler R, Djedovic G, Klocker H, Heidegger I, Strasak A, Loidl W, Bektic J, Skradski V, Horninger W, Oswald J
Quantitative measurement of the androgen receptor in prepuces of boys with and without hypospadias.
Zeige auf PubMed
Zum pdf
BMC CANCER
01. März 2013 - Endocr Relat Cancer
Sampson N, Neuwirt H, Puhr M, Klocker H, Eder IE
In vitro model systems to study androgen receptor signaling in prostate cancer.
Zeige auf PubMed
Zum pdf
08. Februar 2013 - PLoS One
Massoner P, Kugler KG, Unterberger K, Kuner R, Mueller LA, Fälth M, Schäfer G, Seifarth C, Ecker S, Verdorfer I, Graber A, Sültmann H, Klocker H
Characterization of transcriptional changes in ERG rearrangement-positive prostate cancer identifies the regulation of metabolic sensors such as neuropeptide Y.
Zeige auf PubMed
Zum pdf
06. Februar 2013 - Prostate Cancer Prostatic Dis
Schaefer G, Mosquera JM, Ramoner R, Park K, Romanel A, Steiner E, Horninger W, Bektic J, Ladurner-Rennau M, Rubin MA, Demichelis F, Klocker H
Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer.
Zeige auf PubMed
Zum pdf
30. Jänner 2013 - Prostate
Prencipe M, Madden SF, O'Neill A, O'Hurley G, Culhane A, O'Connor D, Klocker H, Kay EW, Gallagher WM, Watson WR
Identification of transcription factors associated with castration-resistance: is the serum responsive factor a potential therapeutic target?
Zeige auf PubMed
Zum pdf
23. Jänner 2013 - Nat Rev Urol
De Zordo T, Stronegger D, Pallwein-Prettner L, Harvey CJ, Pinggera G, Jaschke W, Aigner F, Frauscher F
Multiparametric ultrasonography of the testicles.
Zeige auf PubMed
Zum pdf
11. Jänner 2013 - Scand J Urol
Pichler R, Zangerl F, Leonhartsberger N, Stöhr B, Horninger W, Steiner H
Orthotopic bladder replacement in women: focus on functional results of a retrospective, single-centre study.
Zeige auf PubMed
Zum pdf
09. Jänner 2013 - Chemotherapy
Pichler R, Leonhartsberger N, Stöhr B, Horninger W, Steiner H
Two cycles of cisplatin-based chemotherapy for low-volume stage II seminoma: results of a retrospective, single-center case series.
Zeige auf PubMed
Zum pdf
09. Jänner 2013 - FEBS J
Bu H, Schweiger MR, Manke T, Wunderlich A, Timmermann B, Kerick M, Pasqualini L, Shehu E, Fuchsberger C, Cato AC, Klocker H
Anterior gradient 2 and 3--two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells.
Zeige auf PubMed
Zum pdf
Kurzinformation
02. Jänner 2013 - Front Biosci (Schol Ed)
Culig Z
Suppressors of cytokine signalling-3 and -1 in human carcinogenesis.
Zeige auf PubMed
Zum pdf
19. Dezember 2012 - Int J Biochem Cell Biol
Peng Y, Shi J, Du X, Wang L, Klocker H, Mo L, Mo Z, Zhang J
Prostaglandin E2 induces stromal cell-derived factor-1 expression in prostate stromal cells by activating protein kinase A and transcription factor Sp1.
Zeige auf PubMed
Zum pdf
15. Dezember 2012 - World J Urol
Klinglmair G, Pichler R, Zelger B, Dogan HS, Becker T, Esterbauer J, Riccabona M, Loidl W, Horninger W, Oswald J
Prevalence of the human papillomavirus (HPV) expression of the inner prepuce in asymptomatic boys and men.
Zeige auf PubMed
Zum pdf
11. Dezember 2012 - Anticancer Res
Heidegger I, Ladurner M, Skradski V, Klocker H, Schäfer G, Horninger W, Bektic J
Adverse pathological findings in needle biopsy gleason score 6 prostate cancers with low and intermediate preoperative PSA levels following radical prostatectomy.
Zeige auf PubMed
Zum pdf
30. November 2012 - Endocr Relat Cancer
Culig Z
Rapidly changing endocrine oncology research: personal reflection of the past, present and future times.
Zeige auf PubMed
Zum pdf
15. November 2012 - Oxid Med Cell Longev
Sampson N, Berger P, Zenzmaier C
Therapeutic targeting of redox signaling in myofibroblast differentiation and age-related fibrotic disease.
Zeige auf PubMed
Zum pdf
31. Oktober 2012 - Lab Invest
Neuwirt H, Eder IE, Puhr M, Rudnicki M
SOCS-3 is downregulated in progressive CKD patients and regulates proliferation in human renal proximal tubule cells in a STAT1/3 independent manner.
Zeige auf PubMed
Zum pdf
31. Oktober 2012 - BJU Int
Stoehr B, Schachtner L, Pichler R, Holzner B, Giesinger J, Oberguggenberger A, Leonhartsberger N, Horninger W, Steiner H
Influence of achieved paternity on quality of life in testicular cancer survivors.
Zeige auf PubMed
Zum pdf
30. Oktober 2012 - Expert Opin Ther Targets
Culig Z
Interleukin-6 as a therapy target in oral squamous carcinoma.
Zeige auf PubMed
Zum pdf
09. Oktober 2012 - Am J Pathol
Puhr M, Hoefer J, Schäfer G, Erb HH, Oh SJ, Klocker H, Heidegger I, Neuwirt H, Culig Z
Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205.
Zeige auf PubMed
Zum pdf
15. September 2012 - Int J Exp Pathol
Denzel S, Mack B, Eggert C, Massoner P, Stöcklein N, Kemming D, Harréus U, Gires O
MMP7 is a target of the tumour-associated antigen EpCAM.
Zeige auf PubMed
Zum pdf
06. September 2012 - Endocrinology
Zenzmaier C, Kern J, Sampson N, Heitz M, Plas E, Untergasser G, Berger P
Phosphodiesterase type 5 inhibition reverts prostate fibroblast-to-myofibroblast trans-differentiation.
Zeige auf PubMed
Zum pdf
21. August 2012 - Endocrinology
Heidegger I, Ofer P, Doppler W, Rotter V, Klocker H, Massoner P
Diverse functions of IGF/insulin signaling in malignant and noncancerous prostate cells: proliferation in cancer cells and differentiation in noncancerous cells.
Zeige auf PubMed
Zum pdf
Kurzinformation
14. August 2012 - Am J Pathol
Sampson N, Ruiz C, Zenzmaier C, Bubendorf L, Berger P
PAGE4 positivity is associated with attenuated AR signaling and predicts patient survival in hormone-naive prostate cancer.
Zeige auf PubMed
Zum pdf
07. August 2012 - World J Urol
Pichler R, Klima G, Richter E, Marksteiner R, Mayr V, Skradski V, Horninger W, Oswald J
Autologous fibroblast transplantation at the vesico-ureteral junction as potential reconstructive cell replacement in an animal model.
Zeige auf PubMed
Zum pdf
14. Juli 2012 - Analyst
Pallua JD, Pezzei C, Zelger B, Schaefer G, Bittner LK, Huck-Pezzei VA, Schoenbichler SA, Hahn H, Kloss-Brandstaetter A, Kloss F, Bonn GK, Huck CW
Fourier transform infrared imaging analysis in discrimination studies of squamous cell carcinoma.
Zeige auf PubMed
Zum pdf
25. April 2012 - Clin Cancer Res
Thurnher M, Nussbaumer O, Gruenbacher G
Novel aspects of mevalonate pathway inhibitors as antitumor agents.
Zeige auf PubMed
Zum pdf
25. April 2012 - World J Urol
Ankerst DP, Boeck A, Freedland SJ, Jones JS, Cronin AM, Roobol MJ, Hugosson J, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Moreira DM, Schröder FH, Lilja H, Vickers AJ, Thompson IM
Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
Zeige auf PubMed
Zum pdf
13. April 2012 - Proc Natl Acad Sci U S A
Demichelis F, Setlur SR, Banerjee S, Chakravarty D, Chen JY, Chen CX, Huang J, Beltran H, Oldridge DA, Kitabayashi N, Stenzel B, Schaefer G, Horninger W, Bektic J, Chinnaiyan AM, Goldenberg S, Siddiqui J, Regan MM, Kearney M, Soong TD, Rickman DS, Elemento O, Wei JT, Scherr DS, Sanda MA, Bartsch G, Lee C, Klocker H, Rubin MA
Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.
Zeige auf PubMed
Zum pdf
31. März 2012 - Mod Pathol
Haffner MC, Laimer J, Chaux A, Schäfer G, Obrist P, Brunner A, Kronberger IE, Laimer K, Gurel B, Koller JB, Seifarth C, Zelger B, Klocker H, Rasse M, Doppler W, Bander NH
High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity.
Zeige auf PubMed
Zum pdf
28. März 2012 - Am J Pathol
Hoefer J, Schäfer G, Klocker H, Erb HH, Mills IG, Hengst L, Puhr M, Culig Z
PIAS1 is increased in human prostate cancer and enhances proliferation through inhibition of p21.
Zeige auf PubMed
Zum pdf
Kurzinformation
22. März 2012 - Urol Int
Pichler R, Fritsch H, Skradski V, Horninger W, Schlenck B, Rehder P, Oswald J
Diagnosis and management of pediatric urethral injuries.
Zeige auf PubMed
Zum pdf
13. März 2012 - Qual Life Res
Holzner B, Efficace F, Basso U, Johnson CD, Aaronson NK, Arraras JI, Smith AB, Chow E, Oberguggenberger AS, Bottomley A, Steiner H, Incrocci L, Giesinger JM
Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26.
Zeige auf PubMed
Zum pdf
10. März 2012 - Reprod Fertil Dev
Doyle U, Sampson N, Zenzmaier C, Schwärzler P, Berger P
Seminal plasma enhances and accelerates progesterone-induced decidualisation of human endometrial stromal cells.
Zeige auf PubMed
Zum pdf
08. März 2012 - Radiology
Aigner F, De Zordo T, Pallwein-Prettner L, Junker D, Schäfer G, Pichler R, Leonhartsberger N, Pinggera G, Dogra VS, Frauscher F
Real-time sonoelastography for the evaluation of testicular lesions.
Zeige auf PubMed
Zum pdf
07. März 2012 - World J Urol
Cronauer MV, Culig Z
Molecular aspects of prostate cancer.
Zeige auf PubMed
Zum pdf
06. März 2012 - Eur Urol
Rehder P, Haab F, Cornu JN, Gozzi C, Bauer RM
Treatment of postprostatectomy male urinary incontinence with the transobturator retroluminal repositioning sling suspension: 3-year follow-up.
Zeige auf PubMed
Zum pdf
03. März 2012 - Endocr Relat Cancer
Oh SJ, Erb HH, Hobisch A, Santer FR, Culig Z
Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways.
Zeige auf PubMed
Zum pdf
04. Februar 2012 - Carcinogenesis
Kong L, Schäfer G, Bu H, Zhang Y, Zhang Y, Klocker H
Lamin A/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway.
Zeige auf PubMed
Zum pdf
27. Jänner 2012 - Cancer Immunol Immunother
Leonhartsberger N, Ramoner R, Falkensammer C, Rahm A, Gander H, Höltl L, Thurnher M
Quality of life during dendritic cell vaccination against metastatic renal cell carcinoma.
Zeige auf PubMed
Zum pdf
03. Jänner 2012 - World J Urol
Ankerst DP, Boeck A, Freedland SJ, Thompson IM, Cronin AM, Roobol MJ, Hugosson J, Stephen Jones J, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Moreira DM, Schröder FH, Lilja H, Vickers AJ
Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
Zeige auf PubMed
Zum pdf

Universitätsklinik für Urologie - Labor | Abt. für Experimentelle Urologie | Anichstraße 35, 6020 Innsbruck
Tel.: +43 512 504 24874 | Fax.: +43 512 504 24817 | Email: lki.ur.labor@tirol-kliniken.at